{"content":"<li class=\"n-box-item date-title\" data-end=\"1489550399\" data-start=\"1489464000\" data-txt=\"Sunday, December 22, 2019\">Tuesday, March 14, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3251146\" data-ts=\"1489531013\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXAS\" target=\"_blank\">AXAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251146-abraxas-petroleumplus-13-ah-q4-brings-surprise-profit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Abraxas Petroleum +13% AH as Q4 brings surprise profit</a></h4><ul>     <li>Abraxas Petroleum (NASDAQ:<a href='https://seekingalpha.com/symbol/AXAS' title='Abraxas Petroleum Corporation'>AXAS</a>)&nbsp;<font color='green'>+12.7%</font>&nbsp;AH after reporting a surprise adjusted <a href=\"https://seekingalpha.com/news/3251087-abraxas-petroleum-beats-0_02-beats-revenue\" target=\"_blank\">Q4 profit</a> on a 64% Y/Y improvement in revenues, results the company calls &ldquo;superb&rdquo; in the face of difficult markets last year.</li>     <li>AXAS says 2016 cash operating expenses came in toward the lower end of its guidance range, and January 2017 financial results continue to reflect the improvement  with cash expenses coming in at the low end of guidance; the company says it also has seen a \"tremendous improvement\" in natural gas and natural gas liquids realizations in January.</li>     <li>AXAS says its balance sheet and cash flow position will allow it to execute its program to run a full-time rig in both the Bakken and Permian plays, and it continues to \"pursue several cost-effective bolt-on acquisition opportunities\" in the Delaware Basin.</li></ul><div class=\"tiny-share-widget\" data-id=\"3251146\" data-linked=\"Abraxas Petroleum +13% AH as Q4 brings surprise profit\" data-tweet=\"$AXAS - Abraxas Petroleum +13% AH as Q4 brings surprise profit https://seekingalpha.com/news/3251146-abraxas-petroleumplus-13-ah-q4-brings-surprise-profit?source=tweet\" data-url=\"https://seekingalpha.com/news/3251146-abraxas-petroleumplus-13-ah-q4-brings-surprise-profit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251136\" data-ts=\"1489527491\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251136-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/RST' title='Rosetta Stone Inc.'>RST</a> <font color='green'>+12.2%</font>. <a href='https://seekingalpha.com/symbol/TCON' title='Tracon Pharmaceuticals'>TCON</a> <font color='green'>+11.1%</font>. <a href='https://seekingalpha.com/symbol/MUX' title='McEwen Mining Inc.'>MUX</a> <font color='green'>+5.0%</font>. <a href='https://seekingalpha.com/symbol/CLDX' title='Celldex Therapeutics, Inc'>CLDX</a> <font color='green'>+4.2%</font>. <a href='https://seekingalpha.com/symbol/RRC' title='Range Resources Corporation'>RRC</a> <font color='green'>+3.2%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/RUBI' title='The Rubicon Project, Inc.'>RUBI</a> <font color='red'>-13.6%</font>. <a href='https://seekingalpha.com/symbol/NPTN' title='NeoPhotonics Corporation'>NPTN</a> <font color='red'>-13.4%</font>. <a href='https://seekingalpha.com/symbol/NMM' title='Navios Maritime Partners L.P.'>NMM</a> <font color='red'>-12.0%</font>. <a href='https://seekingalpha.com/symbol/AKAO' title='Achaogen'>AKAO</a> <font color='red'>-9.5%</font>. <a href='https://seekingalpha.com/symbol/FTD' title='FTD Companies, Inc.'>FTD</a> <font color='red'>-8.8%.</font></li> </ul><div class=\"tiny-share-widget\" data-id=\"3251136\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$RST $TCON $MUX - After Hours Gainers / Losers https://seekingalpha.com/news/3251136-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3251136-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251130\" data-ts=\"1489526577\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NMM\" target=\"_blank\">NMM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251130-navios-maritime-to-sell-47_6m-units-in-direct-offering-2_10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Navios Maritime to sell 47.6M units in direct offering at $2.10 each</a></h4><ul><li>Navios Maritime Partners (NYSE:<a href='https://seekingalpha.com/symbol/NMM' title='Navios Maritime Partners L.P.'>NMM</a>) <font color='red'>-11.6%</font>&nbsp;AH&nbsp; after announcing plans to sell ~47.6M common units in a <a href=\"https://seekingalpha.com/pr/16771228-navios-maritime-partners-l-p-announces-100_0-million-offering-2_10-per-common-unit\" target=\"_blank\">direct offering</a> at $2.10/unit, which equates to a 16% discount to today's closing price.</li><li>NMM expects proceeds from the offering of ~$95M, which the company says will be used for general working capital purposes, including vessel  acquisitions.</li></ul><div class=\"tiny-share-widget\" data-id=\"3251130\" data-linked=\"Navios Maritime to sell 47.6M units in direct offering at $2.10 each\" data-tweet=\"$NMM - Navios Maritime to sell 47.6M units in direct offering at $2.10 each https://seekingalpha.com/news/3251130-navios-maritime-to-sell-47_6m-units-in-direct-offering-2_10?source=tweet\" data-url=\"https://seekingalpha.com/news/3251130-navios-maritime-to-sell-47_6m-units-in-direct-offering-2_10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>49&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251116\" data-ts=\"1489525056\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARNA\" target=\"_blank\">ARNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251116-arenas-q4-beat-gooses-shares-up-23-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arena&#39;s Q4 beat gooses shares, up 23% after hours</a></h4><ul><li>Arena Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ARNA' title='Arena Pharmaceuticals, Inc.'>ARNA</a>) <a href=\"https://seekingalpha.com/pr/16771114-arena-pharmaceuticals-provides-corporate-update-reports-fourth-quarter-full-year-2016\" target=\"_blank\">Q4 results</a> ($M): Revenues: 85.4 (+999%); Eisai Collaboration Revenue: 61.5 (+999%); BELVIQ Sales: 26.3 (+317.9%).</li><li>Net Income: 38.6 (+999%); EPS: 0.16 (+223.1%).</li><li><strong>2017 Guidance</strong>: Cash utilization: $80M - 100M.</li><li>The big bump in Eisai-related revenues came from its acquisition of global rights to BELVIQ.</li><li>Consensus views for EPS and revenues were ($0.08) and $15.6M, respectively.</li></ul><div class=\"tiny-share-widget\" data-id=\"3251116\" data-linked=\"Arena&#39;s Q4 beat gooses shares, up 23% after hours\" data-tweet=\"$ARNA - Arena&#39;s Q4 beat gooses shares, up 23% after hours https://seekingalpha.com/news/3251116-arenas-q4-beat-gooses-shares-up-23-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3251116-arenas-q4-beat-gooses-shares-up-23-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251115\" data-ts=\"1489525038\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NPTN\" target=\"_blank\">NPTN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251115-neophotonicsminus-12-q1-2017-outlook-off-considerably\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NeoPhotonics -12%; Q1 2017 outlook off considerably</a></h4><ul><li><strong><a href=\"https://seekingalpha.com/news/3251074-neophotonics-beats-0_05-beats-revenue\" target=\"_blank\">Q4 2016 results</a></strong> &ndash; revenue $109.8M (+23.2% Y/Y,&nbsp;<font color='green'>$2.88M above estimates</font>), EPS $0.13 (<font color='green'>$0.05 above estimates</font>)</li><li><strong>Q1 2017 projections</strong> &ndash; revenue $67M-$73M (<a href=\"https://finance.yahoo.com/quote/NPTN/analysts?p=NPTN\" target=\"_blank\">consensus $98.04M</a>), EPS -$0.20 to -$0.30 (consensus $0.05), gross margin 28%-31%, operating expenses $29M-$31M</li><li><strong>After hours</strong> &ndash; (NYSE:<a href='https://seekingalpha.com/symbol/NPTN' title='NeoPhotonics Corporation'>NPTN</a>) $7.10</li><li><a href=\"https://seekingalpha.com/pr/16771148-neophotonics-reports-record-fourth-quarter-fiscal-year-2016-financial-results\" target=\"_blank\">Press release</a> / <a href=\"http://edge.media-server.com/m/p/5ns6fjin/lan/en\" target=\"_blank\">conference call</a> / <a href=\"https://seekingalpha.com/filing/3459665\" target=\"_blank\">8-K</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3251115\" data-linked=\"NeoPhotonics -12%; Q1 2017 outlook off considerably\" data-tweet=\"$NPTN - NeoPhotonics -12%; Q1 2017 outlook off considerably https://seekingalpha.com/news/3251115-neophotonicsminus-12-q1-2017-outlook-off-considerably?source=tweet\" data-url=\"https://seekingalpha.com/news/3251115-neophotonicsminus-12-q1-2017-outlook-off-considerably\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251112\" data-ts=\"1489524500\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOGL\" target=\"_blank\">GOGL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251112-golden-ocean-to-buy-16-dry-bulk-vessels-in-cash-and-stock-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Golden Ocean to buy 16 dry bulk vessels in cash and stock deal</a></h4><ul>     <li>Golden Ocean (NASDAQ:<a href='https://seekingalpha.com/symbol/GOGL' title='Golden Ocean Group Limited'>GOGL</a>) <font color='red'>-5.9%</font>&nbsp;AH after <a href=\"https://seekingalpha.com/pr/16771180-gogl-acquisition-16-modern-dry-bulk-vessels\" target=\"_blank\">agreeing to acquire</a> 16 modern dry bulk vessels, 14 from subsidiaries of Quintana Shipping and two  ice class Panamax vessels from subsidiaries of  Seatankers, an affiliate of Hemen Holding, the company's largest  shareholder.</li>     <li>In connection with the acquisition, GOGL will issue 17.8M shares and assume $285.2M of debt, and launches an <a href=\"https://seekingalpha.com/pr/16771186-gogl-announcement-commencement-usd-60-million-equity-offering\" target=\"_blank\">equity offering</a> of new shares for gross proceeds of ~$60M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3251112\" data-linked=\"Golden Ocean to buy 16 dry bulk vessels in cash and stock deal\" data-tweet=\"$GOGL - Golden Ocean to buy 16 dry bulk vessels in cash and stock deal https://seekingalpha.com/news/3251112-golden-ocean-to-buy-16-dry-bulk-vessels-in-cash-and-stock-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3251112-golden-ocean-to-buy-16-dry-bulk-vessels-in-cash-and-stock-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251111\" data-ts=\"1489524170\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKAO\" target=\"_blank\">AKAO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251111-achaogens-q4-miss-pressures-shares-down-11-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Achaogen&#39;s Q4 miss pressures shares, down 11% after hours</a></h4><ul><li>Achaogen (NASDAQ:<a href='https://seekingalpha.com/symbol/AKAO' title='Achaogen'>AKAO</a>) <a href=\"https://seekingalpha.com/pr/16771122-achaogen-reports-fourth-quarter-full-year-2016-financial-results-provides-corporate-update\" target=\"_blank\">Q4 results </a>($M): Revenues: 10.7 (+127.7%).</li><li>Net Loss: (29.7) (-162.8%); Loss/Share: (1.04) (-70.5%).</li><li>Shares are down&nbsp;<font color='red'>11%&nbsp;</font>after revenues came in under consensus of $12.4M and the loss/share was worse than expected ($0.49).</li></ul><div class=\"tiny-share-widget\" data-id=\"3251111\" data-linked=\"Achaogen&#39;s Q4 miss pressures shares, down 11% after hours\" data-tweet=\"$AKAO - Achaogen&#39;s Q4 miss pressures shares, down 11% after hours https://seekingalpha.com/news/3251111-achaogens-q4-miss-pressures-shares-down-11-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3251111-achaogens-q4-miss-pressures-shares-down-11-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251109\" data-ts=\"1489524068\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251109-oil-gains-after-hours-on-bullish-supply-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oil gains after hours on bullish supply report</a></h4><ul><li>The API has reported a 531K barrel decline in crude stocks vs. estimates for a 3M barrel build. It would be the first weekly decline since late last year.</li><li><a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a><font color='green'> +1%</font>&nbsp;after hours</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='PowerShares DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/UGA' title='The United States Gasoline ETF, LP'>UGA</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/UHN' title='The United States Diesel-Heating Oil ETF, LP'>UHN</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/OILK' title='ProShares K-1 Free Crude Oil Strategy ETF'>OILK</a>, <a href='https://seekingalpha.com/symbol/OILX' title='Etracs S&P GSCI Crude Oil Total Return Index ETN'>OILX</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3251109\" data-linked=\"Oil gains after hours on bullish supply report\" data-tweet=\"$USO $OIL $UCO - Oil gains after hours on bullish supply report https://seekingalpha.com/news/3251109-oil-gains-after-hours-on-bullish-supply-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3251109-oil-gains-after-hours-on-bullish-supply-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251105\" data-ts=\"1489523735\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RUBI\" target=\"_blank\">RUBI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251105-rubicon-project-guides-low-slips-13_6-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rubicon Project guides low, slips 13.6% after earnings</a></h4><ul>   <li>Rubicon Project (<a href='https://seekingalpha.com/symbol/RUBI' title='The Rubicon Project, Inc.'>RUBI</a> <font color='red'>-2%</font>) has tumbled in postmarket trading, <font color='red'>down 13.6%</font>, after <a href=\"https://seekingalpha.com/news/3251082-rubicon-project-beats-0_22-beats-revenue\" target=\"_blank\">Q4 earnings</a> that beat expectations but contained downbeat guidance for the coming quarter.</li>    <li>Revenue dropped 20% Y/Y and the company swung to a GAAP net loss of $21.2M (from a year-ago profit of $20.4M), with the help of an impairment charge of $23.5M.</li>    <li>EBITDA of $21.7M fell nearly 40% but beat an expected $15.7M.</li>    <li>The company <a href=\"https://seekingalpha.com/news/3251088-rubicon-project-names-barrett-succeed-addante-ceo\" target=\"_blank\">named its new CEO</a>, former Millennial Media chief Michael Barrett.</li>    <li>\"As we move into 2017, we remain focused on signing up more publishers, application developers, and adding inventory to our global exchange, a key component to drive future growth,\" said CEO Frank Addante.</li>    <li>For Q1, it's guiding to non-GAAP net revenue of $41M-$44M, light of consensus for $57.3M; adjusted EBITDA of -$6M to -$4M, vs. expectations for an EBITDA gain of $8.2M, and non-GAAP EPS of -$0.26 to -$0.22 vs. an expected per-share profit of $0.10.</li>    <li><a href=\"https://seekingalpha.com/pr/16771160-rubicon-project-reports-fourth-quarter-2016-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3251105\" data-linked=\"Rubicon Project guides low, slips 13.6% after earnings\" data-tweet=\"$RUBI - Rubicon Project guides low, slips 13.6% after earnings https://seekingalpha.com/news/3251105-rubicon-project-guides-low-slips-13_6-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3251105-rubicon-project-guides-low-slips-13_6-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251097\" data-ts=\"1489523038\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOGO\" target=\"_blank\">FOGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251097-fogo-de-chao-higher-after-guidance-satisfies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fogo de Chao higher after guidance satisfies</a></h4><ul><li>Fogo de Chao (NASDAQ:<a href='https://seekingalpha.com/symbol/FOGO' title='Fogo de Chao'>FOGO</a>) pops after <a href=\"https://seekingalpha.com/pr/16771140-fogo-de-chao-inc-reports-fourth-quarter-fiscal-year-2016-results\" target=\"_blank\">Q4</a> results arrive slightly ahead of expectations.</li><li>Comparable restaurant sales were down 1.0% in the U.S. during the quarter. Brazil restaurant revenue was flat at $12.2M.</li><li>Restaurant contribution margin fell 290 bps to 31.4%.</li><li>Initial guidance from the company for 2017 is for revenue of $315M to $320M vs. $318M consensus&nbsp;and EPS to fall in a range of $0.92 to $0.95 vs. $0.92 consensus. Fogo expects to open seven restaurants this year.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3251079-fogo-de-chao-beats-0_01-beats-revenue\" target=\"_blank\">Fogo de Chao beats by $0.01, beats on revenue</a> (March 14)</li><li>FOGO&nbsp;<font color='green'>+7.92%</font>&nbsp;AH to $14.30.</li></ul><div class=\"tiny-share-widget\" data-id=\"3251097\" data-linked=\"Fogo de Chao higher after guidance satisfies\" data-tweet=\"$FOGO - Fogo de Chao higher after guidance satisfies https://seekingalpha.com/news/3251097-fogo-de-chao-higher-after-guidance-satisfies?source=tweet\" data-url=\"https://seekingalpha.com/news/3251097-fogo-de-chao-higher-after-guidance-satisfies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251091\" data-ts=\"1489522739\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UTHR\" target=\"_blank\">UTHR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251091-united-therapeutics-down-3-over-possible-delay-in-remodulin-infusion-pump\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">United Therapeutics down 3% over possible delay in Remodulin infusion pump</a></h4><ul><li>United Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/UTHR' title='United Therapeutics Corporation'>UTHR</a>) was under pressure today, down&nbsp;<font color='red'>3%</font>&nbsp;on light volume, on a possible delay in releasing a programmable infusion pump for <a href=\"https://www.remodulin.com/\" target=\"_blank\">Remodulin </a>(treprostinil) users.</li><li>RBC's Michael Yee says the heightened risk comes from Medtronic's (NYSE:<a href='https://seekingalpha.com/symbol/MDT' title='Medtronic plc'>MDT</a>) <a href=\"http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRes/res.cfm?ID=150480\" target=\"_blank\">recall </a>of its <a href=\"http://professional.medtronic.com/pt/neuro/idd/prod/synchromed-ii/#.WMhMSfnythE\" target=\"_blank\">SynchroMed II/EL</a> pumps due to a priming bolus issue, which it plans to fix with a software update. A year ago, the FDA rejected Medtronic's marketing application for an implantable pump to deliver Remodulin. The pulmonary arterial hypertension med faces generic competition in 2018 so a delay in offering an implantable pump option would make it more difficult for UTHR to protect sales.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3251091\" data-linked=\"United Therapeutics down 3% over possible delay in Remodulin infusion pump\" data-tweet=\"$UTHR $UTHR $MDT - United Therapeutics down 3% over possible delay in Remodulin infusion pump https://seekingalpha.com/news/3251091-united-therapeutics-down-3-over-possible-delay-in-remodulin-infusion-pump?source=tweet\" data-url=\"https://seekingalpha.com/news/3251091-united-therapeutics-down-3-over-possible-delay-in-remodulin-infusion-pump\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251087\" data-ts=\"1489522623\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXAS\" target=\"_blank\">AXAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251087-abraxas-petroleum-beats-0_02-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Abraxas Petroleum beats by $0.02, beats on revenue</a></h4><ul><li>Abraxas Petroleum (NASDAQ:<a href='https://seekingalpha.com/symbol/AXAS' title='Abraxas Petroleum Corporation'>AXAS</a>): Q4 EPS of $0.01 <font color='green'>beats by $0.02</font>.</li><li>Revenue of $22M (+64.8% Y/Y) <font color='green'>beats by $1.74M</font>.</li><li>Shares <font color='green'>+3.2%</font>.</li><li><a href='https://seekingalpha.com/pr/16771168-abraxas-announces-2016-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3251087\" data-linked=\"Abraxas Petroleum beats by $0.02, beats on revenue\" data-tweet=\"$AXAS - Abraxas Petroleum beats by $0.02, beats on revenue https://seekingalpha.com/news/3251087-abraxas-petroleum-beats-0_02-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3251087-abraxas-petroleum-beats-0_02-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251079\" data-ts=\"1489522402\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOGO\" target=\"_blank\">FOGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251079-fogo-de-chao-beats-0_01-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fogo de Chao beats by $0.01, beats on revenue</a></h4><ul><li>Fogo de Chao (NASDAQ:<a href='https://seekingalpha.com/symbol/FOGO' title='Fogo de Chao'>FOGO</a>): Q4 EPS of $0.28 <font color='green'>beats by $0.01</font>.</li><li>Revenue of $80.9M (+4.4% Y/Y) <font color='green'>beats by $3.83M</font>.</li><li>Shares <font color='green'>+2.3%</font>.</li><li><a href='https://seekingalpha.com/pr/16771140-fogo-de-chao-inc-reports-fourth-quarter-fiscal-year-2016-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3251079\" data-linked=\"Fogo de Chao beats by $0.01, beats on revenue\" data-tweet=\"$FOGO - Fogo de Chao beats by $0.01, beats on revenue https://seekingalpha.com/news/3251079-fogo-de-chao-beats-0_01-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3251079-fogo-de-chao-beats-0_01-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251066\" data-ts=\"1489521897\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLDX\" target=\"_blank\">CLDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251066-celldex-beats-0_04-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Celldex beats by $0.04, beats on revenue</a></h4><ul><li>Celldex (NASDAQ:<a href='https://seekingalpha.com/symbol/CLDX' title='Celldex Therapeutics, Inc'>CLDX</a>): Q4 EPS of -$0.30 <font color='green'>beats by $0.04</font>.</li><li>Revenue of $1.9M (+6.1% Y/Y) <font color='green'>beats by $0.82M</font>.</li><li>Shares <font color='green'>+2.7%</font>.</li><li><a href='https://seekingalpha.com/pr/16771119-celldex-provides-corporate-update-reports-full-year-2016-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3251066\" data-linked=\"Celldex beats by $0.04, beats on revenue\" data-tweet=\"$CLDX - Celldex beats by $0.04, beats on revenue https://seekingalpha.com/news/3251066-celldex-beats-0_04-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3251066-celldex-beats-0_04-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251063\" data-ts=\"1489521758\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARNA\" target=\"_blank\">ARNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251063-arena-pharmaceuticals-beats-0_24-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arena Pharmaceuticals beats by $0.24, beats on revenue</a></h4><ul><li>Arena Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ARNA' title='Arena Pharmaceuticals, Inc.'>ARNA</a>): Q4 EPS of $0.16 <font color='green'>beats by $0.24</font>.</li><li>Revenue of $85.4M (+1001.9% Y/Y) <font color='green'>beats by $69.82M</font>.</li><li>Shares <font color='green'>+16%</font>.</li><li><a href='https://seekingalpha.com/pr/16771114-arena-pharmaceuticals-provides-corporate-update-reports-fourth-quarter-full-year-2016'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3251063\" data-linked=\"Arena Pharmaceuticals beats by $0.24, beats on revenue\" data-tweet=\"$ARNA - Arena Pharmaceuticals beats by $0.24, beats on revenue https://seekingalpha.com/news/3251063-arena-pharmaceuticals-beats-0_24-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3251063-arena-pharmaceuticals-beats-0_24-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251056\" data-ts=\"1489521576\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CORV\" target=\"_blank\">CORV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251056-cardiome-cleared-to-commercialize-brinavess-in-canada-shares-ahead-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cardiome cleared to commercialize Brinavess in Canada; shares ahead 2%</a></h4><ul><li>Thinly traded nano cap Cardiome Pharma (CRME <font color='green'>+2%</font>) heads north on triple normal volume, albeit on turnover of only 94K shares, in response to its <a href=\"https://seekingalpha.com/pr/16771079-cardiome-receives-notice-compliance-health-canada-brinavess-nds\" target=\"_blank\">announcement </a>that it has received a Notice of Compliance for BRINAVESS (vernakalant hydrochloride, IV) from Health Canada which enables the company to begin commercializing the product there.</li><li>BRINAVESS is indicated for the rapid conversion of recent-onset atrial fibrillation to sinus rhythm in certain patients.</li><li>Cardiome plans to meet with the FDA next month related to advancing development in the U.S. Vernakalant IV has been on clinical hold since 2010.</li></ul><div class=\"tiny-share-widget\" data-id=\"3251056\" data-linked=\"Cardiome cleared to commercialize Brinavess in Canada; shares ahead 2%\" data-tweet=\"$CORV - Cardiome cleared to commercialize Brinavess in Canada; shares ahead 2% https://seekingalpha.com/news/3251056-cardiome-cleared-to-commercialize-brinavess-in-canada-shares-ahead-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3251056-cardiome-cleared-to-commercialize-brinavess-in-canada-shares-ahead-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251067\" data-ts=\"1489521507\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EQNR\" target=\"_blank\">EQNR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251067-statoil-reports-gas-leak-asgard-field\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Statoil reports gas leak at Asgard field</a></h4><ul>     <li>Statoil (STO <font color='red'>-2.5%</font>) says it has launched an investigation into a <a href=\"https://www.energyvoice.com/oilandgas/134013/statoil-admits-25-tonne-gas-leak/\" target=\"_blank\">gas leak</a> at its &Aring;sgard field offshore Norway in which 25 tons of natural gas leaked out during well preparations.</li><li>It is just the latest in string of safety incidents for STO; last week, Norway's PSA safety authority found the company in breach of  regulations in a fire that broke out on a North  Sea platform after crude oil pumped against a closed valve for nearly  an hour.</li><li>The Asgard field is one of the largest developments offshore Norway,  with 63 production and injection wells drilled through  19 subsea templates.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3251067\" data-linked=\"Statoil reports gas leak at Asgard field\" data-tweet=\"$EQNR - Statoil reports gas leak at Asgard field https://seekingalpha.com/news/3251067-statoil-reports-gas-leak-asgard-field?source=tweet\" data-url=\"https://seekingalpha.com/news/3251067-statoil-reports-gas-leak-asgard-field\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251052\" data-ts=\"1489520800\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSRO\" target=\"_blank\">TSRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251052-tesarominus-14-and-clovisplus-10-go-opposite-ways-on-astrazenecas-lynparza-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TESARO (-14%) and Clovis (+10%) go opposite ways on AstraZeneca&#39;s Lynparza data</a></h4><ul><li>Positive data from a Phase 3 clinical trial of AstraZeneca's PARP inhibitor Lynparza has TESARO (<a href='https://seekingalpha.com/symbol/TSRO' title='Tesaro'>TSRO</a> <font color='red'>-13.6%</font>) reeling and Clovis Oncology (<a href='https://seekingalpha.com/symbol/CLVS' title='Clovis Oncology'>CLVS</a> <font color='green'>+10.4%</font>) rocking.</li><li>TESARO is slumping because Lynparza's benefit as maintenance therapy in ovarian cancer may be a bit better than its PARP candidate niraparib. Its U.S. marketing application is currently under FDA review for a broader indication than Lynparza.</li><li>Clovis is rallying because investors believe the positive data will goose sales of PARP inhibitor Rubraca (rucaparib), OK'd by the FDA to treat ovarian cancer in December 2016.</li></ul><div class=\"tiny-share-widget\" data-id=\"3251052\" data-linked=\"TESARO (-14%) and Clovis (+10%) go opposite ways on AstraZeneca&#39;s Lynparza data\" data-tweet=\"$TSRO $TSRO $CLVS - TESARO (-14%) and Clovis (+10%) go opposite ways on AstraZeneca&#39;s Lynparza data https://seekingalpha.com/news/3251052-tesarominus-14-and-clovisplus-10-go-opposite-ways-on-astrazenecas-lynparza-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3251052-tesarominus-14-and-clovisplus-10-go-opposite-ways-on-astrazenecas-lynparza-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251054\" data-ts=\"1489520602\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLIT\" target=\"_blank\">HLIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251054-harmonicminus-5_1-drexel-returns-to-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Harmonic -5.1% as Drexel returns to sidelines</a></h4><ul>   <li>Harmonic (NASDAQ:<a href='https://seekingalpha.com/symbol/HLIT' title='Harmonic Inc.'>HLIT</a>) is <font color='red'>5.1% lower</font> today on heavy volume after Drexel Hamilton has headed to the sidelines on the stock.</li>    <li>The firm's Greg Mesniaeff downgraded Harmonic to Hold from a previous Buy rating. Drexel had previously bumped it from Hold to Buy in August.</li>    <li>Harmonic is <font color='green'>up 0.9%</font> since it beat expectations with earnings at February's end, and hit a 52-week high last Wednesday.</li>    <li>It's <font color='green'>up 11%</font> YTD and <font color='green'>up 76.8%</font> over the past 12 months.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3251054\" data-linked=\"Harmonic -5.1% as Drexel returns to sidelines\" data-tweet=\"$HLIT - Harmonic -5.1% as Drexel returns to sidelines https://seekingalpha.com/news/3251054-harmonicminus-5_1-drexel-returns-to-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3251054-harmonicminus-5_1-drexel-returns-to-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251053\" data-ts=\"1489520578\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRO\" target=\"_blank\">MRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251053-marathon-oil-reiterated-hold-canaccord-after-sharp-loss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marathon Oil reiterated Hold at Canaccord after sharp loss</a></h4><ul>     <li>Marathon Oil (<a href='https://seekingalpha.com/symbol/MRO' title='Marathon Oil Corporation'>MRO</a> <font color='red'>-3.3%</font>) has given up all its gains that followed <a href=\"https://seekingalpha.com/news/3249957-marathon-oil-plus-3-percent-sales-flurry-one-premarket-oil-gas-gainers\" target=\"_blank\">last Thursday's news</a> that it sold all its interests in Canada's Athbasca oil sands for $2.5B and bought 70K net surface acres in the Permian Basin for $1.1B.</li>     <li>Canaccord Genuity <a href=\"http://247wallst.com/energy-business/2017/03/14/what-canaccord-genuity-likes-about-marathon-oils-recent-transactions/\" target=\"_blank\">reiterates its Hold rating</a> and $17 price target on the shares, calling the exit from Canada a &ldquo;win-win&rdquo; both for MRO and for buyers Royal Dutch Shell and Canadian Natural Resources.</li>     <li>The firm says the Canada exit simplifies MRO's portfolio while shifting to lower cost, higher margin resource plays in the U.S., represents a 15x multiple on 2016 operating cash flow, eliminates material future capex requirements for a non-operated asset and - including the Permian acquisition - is expected to result in a 25% reduction in total operating expenses in 2017.</li>     <li>Canaccord also highlights MRO&rsquo;s strong financial position, noting that total liquidity at year-end 2016 equaled $5.8B and will bump up to ~$7.2B following the two transactions.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3251053\" data-linked=\"Marathon Oil reiterated Hold at Canaccord after sharp loss\" data-tweet=\"$MRO - Marathon Oil reiterated Hold at Canaccord after sharp loss https://seekingalpha.com/news/3251053-marathon-oil-reiterated-hold-canaccord-after-sharp-loss?source=tweet\" data-url=\"https://seekingalpha.com/news/3251053-marathon-oil-reiterated-hold-canaccord-after-sharp-loss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251051\" data-ts=\"1489520143\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AZN\" target=\"_blank\">AZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251051-astrazenecas-lynparza-shows-significant-survival-benefit-in-late-stage-ovarian-cancer-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AstraZeneca&#39;s Lynparza shows significant survival benefit in late-stage ovarian cancer study; shares ahead 1%</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/16771054-lynparza-olaparib-phase-iii-solominus-2-data-demonstrated-progression-free-survival-benefit\" target=\"_blank\">Results </a>from a Phase 3 clinical trial, SOLO-2, assessing AstraZeneca's (<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca Group plc'>AZN</a> <font color='green'>+1%</font>) PARP inhibitor Lynparza (olaparib) as maintenance therapy in ovarian cancer showed a pronounced extension in survival compared to placebo. The data were presented at the Society of Gynecologic Oncology meeting in National Harbor, MD.</li><li>The study met its primary endpoint of a statistically significant improvement in progression-free survival &#40;PFS&#41; versus placebo. Patients receiving Lynparza experienced median PFS of 19.1 months compared to 5.5 months for placebo (p&lt;0.0001). When measured by blinded independent central review, the difference was even more dramatic: 30.2 months vs. 5.5 months (p&lt;0.0001).</li><li>The Lynparza cohort also demonstrated a statistically significant benefit in time to second progression or death (p=0.0002) (hazard ratio = 0.50) (median not reached vs. 18.4 months).</li><li>The safety profile for participants treated with Lynparza tablets was generally consistent with those observed with the currently approved capsule formulation.</li><li>The company plans to work with regulators to make the tablet formulation available to patients as soon as feasible since tablets reduce the pill burden to four/day from 16/day.</li></ul><div class=\"tiny-share-widget\" data-id=\"3251051\" data-linked=\"AstraZeneca&#39;s Lynparza shows significant survival benefit in late-stage ovarian cancer study; shares ahead 1%\" data-tweet=\"$AZN - AstraZeneca&#39;s Lynparza shows significant survival benefit in late-stage ovarian cancer study; shares ahead 1% https://seekingalpha.com/news/3251051-astrazenecas-lynparza-shows-significant-survival-benefit-in-late-stage-ovarian-cancer-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3251051-astrazenecas-lynparza-shows-significant-survival-benefit-in-late-stage-ovarian-cancer-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251047\" data-ts=\"1489519189\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251047-treasurys-catch-bid-ahead-of-rate-hike\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Treasurys catch a bid ahead of rate hike</a></h4><ul><li>The FOMC today began its two-day policy meeting, the result of which is universally expected to be a 25 basis point rate hike tomorrow.</li><li>The language in the policy statement will be of interest, as will the updated economic projections, the \"dots,\" and Yellen's press conference. Have expectations at the central bank shifted from three rate hikes this year to four?</li><li>Also interesting is that the rate hike will be coming amid a fairly quick plunge in the price of oil - down more than $6 per barrel this month. The Fed could be upping its growth, inflation, and interest rate forecasts at just the moment when oil is signaling the opposite.</li><li>The 10-year yield today has backed off three basis points to 2.59%. <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a>&nbsp;<font color='green'>+0.6%</font>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a>&nbsp;<font color='red'>-1.2%</font></li><li>Previously: <a href=\"https://seekingalpha.com/news/3250905-oil-tumbles-new-lows-saudis-report-boosted-output\" target=\"_blank\">Oil tumbles to new lows as Saudis report boosted output</a> (March 14)</li><li>ETFs: <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a>, <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a>, <a href='https://seekingalpha.com/symbol/TMV' title='Direxion Daily 20+ Year Treasury Bear 3x Shares ETF'>TMV</a>, <a href='https://seekingalpha.com/symbol/TBF' title='ProShares Short 20+ Year Treasury ETF'>TBF</a>, <a href='https://seekingalpha.com/symbol/EDV' title='Vanguard Extended Duration Treasury ETF'>EDV</a>, <a href='https://seekingalpha.com/symbol/TMF' title='Direxion Daily 30-Year Treasury Bull 3x Shares ETF'>TMF</a>, <a href='https://seekingalpha.com/symbol/TTT' title='ProShares UltraPro Short 20+ Year Treasury ETF'>TTT</a>, <a href='https://seekingalpha.com/symbol/ZROZ' title='PIMCO 25+ Year Zero Coupon U.S. Treasury Index ETF'>ZROZ</a>, <a href='https://seekingalpha.com/symbol/VGLT' title='Vanguard Long-Term Government Bond Index ETF'>VGLT</a>, <a href='https://seekingalpha.com/symbol/TLH' title='iShares 10-20 Year Treasury Bond ETF'>TLH</a>, <a href='https://seekingalpha.com/symbol/UBT' title='ProShares Ultra 20+ Year Treasury ETF'>UBT</a>, <a href='https://seekingalpha.com/symbol/DLBS' title='iPath U.S. Treasury Long Bond Bear ETN'>DLBS</a>, <a href='https://seekingalpha.com/symbol/TLO' title='SPDR Barclays Long Term Treasury ETF'>TLO</a>, <a href='https://seekingalpha.com/symbol/VUSTX' title='Vanguard Long Term Treasury Fund Inv'>VUSTX</a>, <a href='https://seekingalpha.com/symbol/DLBL' title='iPath U.S. Treasury Long Bond Bull ETN'>DLBL</a>, <a href='https://seekingalpha.com/symbol/TYBS' title='Direxion Daily 20+ Year Treasury Bear 1x Shares ETF'>TYBS</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3251047\" data-linked=\"Treasurys catch a bid ahead of rate hike\" data-tweet=\"$TLT $TBT $TMV - Treasurys catch a bid ahead of rate hike https://seekingalpha.com/news/3251047-treasurys-catch-bid-ahead-of-rate-hike?source=tweet\" data-url=\"https://seekingalpha.com/news/3251047-treasurys-catch-bid-ahead-of-rate-hike\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251044\" data-ts=\"1489518035\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251044-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/DRWI' title='DragonWave Inc.'>DRWI</a> <font color='green'>+78%</font>. <a href='https://seekingalpha.com/symbol/IOTS' title='Adesto Technologies'>IOTS</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/BV-OLD' title='Bazaarvoice'>BV-OLD</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/ALSK' title='Alaska Communications Systems Group, Inc.'>ALSK</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/UPLD' title='Upland Software'>UPLD</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ICLD-OLD' title='InterCloud Systems, Inc.'>ICLD</a> <font color='red'>-36%</font>. <a href='https://seekingalpha.com/symbol/COUP' title='Coupa Software Inc'>COUP</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/RNVA' title='Rennova Health, Inc.'>OTCPK:RNVA</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/NIHD' title='NII Holdings, Inc.'>NIHD</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/IPAS' title='IPASS INC'>IPAS</a> <font color='red'>-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3251044\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$DRWI $IOTS $BV-OLD - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3251044-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3251044-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251039\" data-ts=\"1489516004\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MMM\" target=\"_blank\">MMM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251039-3m-dips-during-conference-presentation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">3M dips during conference presentation</a></h4><ul><li>There's no webcast thanks to the storm, but the JPMorgan Aviation, Transportation, and Industrials Conference goes on in NYC.</li><li>3M (<a href='https://seekingalpha.com/symbol/MMM' title='3M Company'>MMM</a> <font color='red'>-0.7%</font>) CFO&nbsp;Nick Gangestad takes note of softness in the company's consumer unit early this year. Industrial and electronics units, on the other hand, are off to a strong start.</li><li>Looking south, there's strength in Mexico, but uncertainty in Brazil.</li><li>Shares&nbsp;<font color='red'>fell more than 1%</font>&nbsp;as his remarks hit the tape, currently&nbsp;<font color='red'>down 0.65%</font>.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3251039\" data-linked=\"3M dips during conference presentation\" data-tweet=\"$MMM - 3M dips during conference presentation https://seekingalpha.com/news/3251039-3m-dips-during-conference-presentation?source=tweet\" data-url=\"https://seekingalpha.com/news/3251039-3m-dips-during-conference-presentation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:26 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251038\" data-ts=\"1489515981\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HAL\" target=\"_blank\">HAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251038-halliburton-plenty-of-reasons-to-seek-aker-solutions-analyst-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Halliburton has plenty of reasons to seek Aker Solutions, analyst says</a></h4><ul><li>Reports that Halliburton (<a href='https://seekingalpha.com/symbol/HAL' title='Halliburton Company'>HAL</a> <font color='red'>-2.2%</font>) is <a href=\"https://seekingalpha.com/news/3250882-report-halliburton-near-deal-buy-aker-solutions\" target=\"_blank\">near a deal to buy</a> Aker Solutions are <a href=\"http://www.reuters.com/article/aker-solutions-halliburton-idUSO9N1G101V\" target=\"_blank\">dismissed</a> by Aker ASA, RBC analyst Kurt Hallead sees some <a href=\"http://blogs.barrons.com/stockstowatchtoday/2017/03/14/yes-yes-halliburton-is-always-buying-something/\" target=\"_blank\">compelling reasons</a> why HAL might be interested in the Norwegian oil services company.</li><li>Aker would give HAL a similar product suite as chief competitors Schlumberger (<a href='https://seekingalpha.com/symbol/SLB' title='Schlumberger Limited'>SLB</a> <font color='red'>-0.1%</font>) and Baker Hughes (BHI <font color='red'>-0.3%</font>)/General Electric (<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a> <font color='red'>-1.2%</font>), Hallead says, adding that a deal could make sense from a competitive framework but that HAL has never indicated that it felt subsea was a missing piece to its product and service offering.</li></ul><div class=\"tiny-share-widget\" data-id=\"3251038\" data-linked=\"Halliburton has plenty of reasons to seek Aker Solutions, analyst says\" data-tweet=\"$HAL $HAL $SLB - Halliburton has plenty of reasons to seek Aker Solutions, analyst says https://seekingalpha.com/news/3251038-halliburton-plenty-of-reasons-to-seek-aker-solutions-analyst-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3251038-halliburton-plenty-of-reasons-to-seek-aker-solutions-analyst-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:26 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251036\" data-ts=\"1489515004\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251036-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/KMG' title='KMG Chemicals, Inc.'>KMG</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/PLG' title='Platinum Group Metals Ltd'>PLG</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/UEC' title='Uranium Energy Corp'>UEC</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CHKR' title='Chesapeake Granite Wash Trust'>CHKR</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/EGY' title='VAALCO Energy, Inc.'>EGY</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/IPI' title='Intrepid Potash, Inc.'>IPI</a> <font color='red'>-10%</font>. PGH <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/ICD' title='Independence Contract Drilling'>ICD</a> <font color='red'>-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3251036\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$KMG $PLG $UEC - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3251036-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3251036-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251035\" data-ts=\"1489514552\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251035-traders-up-hedging-efforts-oils-slide-continues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Traders up hedging efforts as oil&#39;s slide continues</a></h4><ul><li>The price of crude oil is down yet again today, and at $47.62, hitting its lowest level since November.</li><li>The move is leading to a sizable pickup in put volume on energy-focused ETFs, according to Bloomberg.</li><li>Looking at the SPDR S&amp;P Oil &amp; Gas Exploration &amp; Production ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/XOP' title='SPDR S&P Oil & Gas Exploration & Production ETF'>XOP</a>), put volume is nearly triple the 20-day average and more than 5x call trades.</li><li>As for oil itself, put volume on the <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a> is double the 20-day moving average and double call trades.</li><li>Previously:&nbsp;<a href=\"https://seekingalpha.com/news/3250905-oil-tumbles-new-lows-saudis-report-boosted-output\" target=\"_blank\">Oil tumbles to new lows as Saudis report boosted output</a>&nbsp;(March 14)</li></ul><div class=\"tiny-share-widget\" data-id=\"3251035\" data-linked=\"Traders up hedging efforts as oil&#39;s slide continues\" data-tweet=\"$XOP $USO - Traders up hedging efforts as oil&#39;s slide continues https://seekingalpha.com/news/3251035-traders-up-hedging-efforts-oils-slide-continues?source=tweet\" data-url=\"https://seekingalpha.com/news/3251035-traders-up-hedging-efforts-oils-slide-continues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251033\" data-ts=\"1489514242\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WBA\" target=\"_blank\">WBA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251033-walgreens-working-to-sell-stores-to-freds-bloomberg\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Walgreens working to sell more stores to Fred&#39;s - Bloomberg</a></h4><ul><li>Bloomberg reports that Walgreen Boots Alliance (<a href='https://seekingalpha.com/symbol/WBA' title='Walgreens Boots Alliance, Inc.'>WBA</a> <font color='red'>-0.7%</font>) is working on a deal to sell more stores to Fred's (<a href='https://seekingalpha.com/symbol/FRED' title='Fred&#39;s, Inc.'>FRED</a> <font color='green'>+2.5%</font>) in order to gain regulatory acceptance for its Rite Aid (<a href='https://seekingalpha.com/symbol/RAD' title='Rite Aid Corporation'>RAD</a> <font color='green'>+3%</font>) merger.</li><li>Shares of Fred's and Rite Aid have broken higher in the last 30 minutes off the development.</li></ul><div class=\"tiny-share-widget\" data-id=\"3251033\" data-linked=\"Walgreens working to sell more stores to Fred&#39;s - Bloomberg\" data-tweet=\"$WBA $WBA $FRED - Walgreens working to sell more stores to Fred&#39;s - Bloomberg https://seekingalpha.com/news/3251033-walgreens-working-to-sell-stores-to-freds-bloomberg?source=tweet\" data-url=\"https://seekingalpha.com/news/3251033-walgreens-working-to-sell-stores-to-freds-bloomberg\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>129&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251030\" data-ts=\"1489513497\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHAK\" target=\"_blank\">SHAK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251030-winter-storm-impact-gauged\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Winter storm impact gauged</a></h4><ul><li>Shake Shack (NYSE:<a href='https://seekingalpha.com/symbol/SHAK' title='Shake Shack'>SHAK</a>) is&nbsp;<font color='red'>down 7.25%</font>&nbsp;over the last few sessions as investors may be gauging the impact of the widespread East Coast snow on the company's Q1 sales.</li><li>Maxim <a href=\"http://www.barrons.com/articles/blizzard-2017-shake-shack-in-the-eye-of-the-storm-1489441111\" target=\"_blank\">estimates</a> that 70% of Shake Shack's revenue is from the U.S. Northeast.</li><li>Dunkin' Brands (NASDAQ:<a href='https://seekingalpha.com/symbol/DNKN' title='Dunkin&#39; Brands'>DNKN</a>) has almost the same exposure, but is only&nbsp;<font color='red'>1.4% lower&nbsp;</font>over the same time period.</li><li>A flip side to strong storms is the impact on restaurant demand if widespread power outages occur. Chains such as Domino's Pizza (<a href='https://seekingalpha.com/symbol/DPZ' title='Domino&#39;s Pizza, Inc.'>DPZ</a> <font color='red'>-1.9%</font>) and Papa John's International (<a href='https://seekingalpha.com/symbol/PZZA' title='Papa John&#39;s International, Inc.'>PZZA</a> <font color='red'>-0.8%</font>) have reported outage-related sales bursts in the past</li></ul><div class=\"tiny-share-widget\" data-id=\"3251030\" data-linked=\"Winter storm impact gauged\" data-tweet=\"$SHAK $SHAK $DNKN - Winter storm impact gauged https://seekingalpha.com/news/3251030-winter-storm-impact-gauged?source=tweet\" data-url=\"https://seekingalpha.com/news/3251030-winter-storm-impact-gauged\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251028\" data-ts=\"1489512563\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251028-small-caps-give-up-2017-gains\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Small caps give up 2017 gains</a></h4><ul><li>This just in:&nbsp;<font color='red'>Down another 0.85%</font>&nbsp;today, the Russell 2000 has returned to flat on the year vs.&nbsp;<font color='green'>5%+ gains</font>&nbsp;for the Dow and S&amp;P 500 and an&nbsp;<font color='green'>8.7% advance</font>&nbsp;for the Nasdaq. Is the divergence something to worry about?</li><li>On a year-over-year basis, the Russell 2000 remains in the lead,&nbsp;<font color='green'>up 25%</font>&nbsp;vs.&nbsp;<font color='green'>23%</font>&nbsp;for the Nasdaq,&nbsp;<font color='green'>21%</font>&nbsp;for the Dow, and&nbsp;<font color='green'>17%</font>&nbsp;for the S&amp;P 500.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/VB' title='Vanguard Small Cap ETF'>VB</a>, <a href='https://seekingalpha.com/symbol/VBR' title='Vanguard Small-Cap Value ETF'>VBR</a>, <a href='https://seekingalpha.com/symbol/VBK' title='Vanguard Small Cap Growth ETF'>VBK</a>, <a href='https://seekingalpha.com/symbol/SCHA' title='Schwab U.S. Small-Cap ETF'>SCHA</a>, <a href='https://seekingalpha.com/symbol/EES' title='WisdomTree SmallCap Earnings ETF'>EES</a>, <a href='https://seekingalpha.com/symbol/RVT' title='Royce Value Trust'>RVT</a>, <a href='https://seekingalpha.com/symbol/FFTY' title='Innovator IBD 50 Fund'>FFTY</a>, <a href='https://seekingalpha.com/symbol/JKL' title='iShares Morningstar Small-Cap Value ETF'>JKL</a>, <a href='https://seekingalpha.com/symbol/RCG' title='RENN Global Entrepreneurs Fund'>RCG</a>, <a href='https://seekingalpha.com/symbol/TILT' title='FlexShares Morningstar U.S. Market Factor Tilt Index ETF'>TILT</a>, <a href='https://seekingalpha.com/symbol/JKJ' title='iShares Morningstar Small-Cap ETF'>JKJ</a>, <a href='https://seekingalpha.com/symbol/FYX' title='First Trust Small Cap Core AlphaDEX ETF'>FYX</a>, <a href='https://seekingalpha.com/symbol/JKK' title='iShares Morningstar Small-Cap Growth ETF'>JKK</a>, <a href='https://seekingalpha.com/symbol/FYT' title='First Trust Small Cap Value AlphaDEX ETF'>FYT</a>, <a href='https://seekingalpha.com/symbol/VLU' title='SPDR S&P 1500 Value Title ETF'>VLU</a>, <a href='https://seekingalpha.com/symbol/FYC' title='First Trust Small Cap Growth AlphaDEX ETF'>FYC</a>, <a href='https://seekingalpha.com/symbol/SMLF' title='iShares Edge MSCI Multifactor USA Small-Cap ETF'>SMLF</a>, <a href='https://seekingalpha.com/symbol/JSML' title='Janus Small Cap Growth Alpha ETF'>JSML</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3251028\" data-linked=\"Small caps give up 2017 gains\" data-tweet=\"$VB $VBR $VBK - Small caps give up 2017 gains https://seekingalpha.com/news/3251028-small-caps-give-up-2017-gains?source=tweet\" data-url=\"https://seekingalpha.com/news/3251028-small-caps-give-up-2017-gains\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251018\" data-ts=\"1489510809\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251018-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MGI' title='MoneyGram International, Inc.'>MGI</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/GDOT' title='Green Dot Corporation'>GDOT</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/CARV' title='Carver Bancorp, Inc.'>CARV</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/JP' title='Jupai Holdings'>JP</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> WAC <font color='red'>-37%</font>. <a href='https://seekingalpha.com/symbol/PN' title='Patriot National, Inc.'>PN</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/ZAIS' title='ZAIS Group Holdings'>ZAIS</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/TPL' title='Texas Pacific Land Trust'>TPL</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/CIA' title='Citizens, Inc.'>CIA</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3251018\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$MGI $GDOT $CARV - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3251018-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3251018-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251011\" data-ts=\"1489510276\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251011-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/DRWI' title='DragonWave Inc.'>DRWI</a> <font color='green'>+65%</font>. <a href='https://seekingalpha.com/symbol/MGI' title='MoneyGram International, Inc.'>MGI</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/NVCN' title='Neovasc Inc.'>NVCN</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/RT' title='Ruby Tuesday, Inc.'>RT</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/KMG' title='KMG Chemicals, Inc.'>KMG</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/BASI' title='Bioanalytical Systems, Inc.'>BASI</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/HPJ' title='Highpower International, Inc.'>HPJ</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/CVRS' title='Corindus Vascular Robotics, Inc.'>CVRS</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/NDLS' title='Noodles & Company'>NDLS</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/GDOT' title='Green Dot Corporation'>GDOT</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> WAC <font color='red'>-41%</font>. <a href='https://seekingalpha.com/symbol/ADPT' title='Adeptus Health'>ADPT</a> <font color='red'>-33%</font>. <a href='https://seekingalpha.com/symbol/ICLD-OLD' title='InterCloud Systems, Inc.'>ICLD</a> <font color='red'>-25%</font>. <a href='https://seekingalpha.com/symbol/PN' title='Patriot National, Inc.'>PN</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/PETX' title='Aratana Therapeutics'>PETX</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/AUPH' title='Aurinia Pharmaceuticals Inc.'>AUPH</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/INNL' title='Innocoll'>INNL</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/EGY' title='VAALCO Energy, Inc.'>EGY</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/CUI' title='CUI Global, Inc.'>CUI</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/AMOT' title='Allied Motion Technologies, Inc.'>AMOT</a> <font color='red'>-15%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3251011\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$DRWI $MGI $NVCN - Midday Gainers / Losers https://seekingalpha.com/news/3251011-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3251011-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:51 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251009\" data-ts=\"1489509926\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RDS.A\" target=\"_blank\">RDS.A</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251009-energy-drags-averages-lower-weighed-sinking-crude-oil\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy drags averages lower, weighed by sinking crude oil</a></h4><ul><li><a href=\"http://www.marketwatch.com/story/us-stocks-set-to-pull-back-with-fed-meeting-in-focus-2017-03-14\" target=\"_blank\">Energy leads the broader market lower</a>, with crude oil on track to close  at fresh 2017 lows for the fourth straight session, after OPEC&nbsp;data showed Saudi Arabia  <a href=\"https://seekingalpha.com/news/3250905-oil-tumbles-new-lows-saudis-report-boosted-output\" target=\"_blank\">raised oil production last month</a>.</li><li>WTI crude <font color='red'>-2.1%</font> at $47.36/bbl; Brent <font color='red'>-1.7%</font> at $50.47/bbl.</li><li>Among the global oil majors: <a href='https://seekingalpha.com/symbol/RDS.A' title='Royal Dutch Shell plc'>RDS.A</a> <font color='red'>-2.1%</font>, <a href='https://seekingalpha.com/symbol/BP' title='BP p.l.c.'>BP</a> <font color='red'>-1.9%</font>, <a href='https://seekingalpha.com/symbol/TOT' title='TOTAL S.A.'>TOT</a> <font color='red'>-1.9%</font>, <a href='https://seekingalpha.com/symbol/CVX' title='Chevron Corporation'>CVX</a> <font color='red'>-1.5%</font>, <a href='https://seekingalpha.com/symbol/XOM' title='Exxon Mobil Corporation'>XOM</a> <font color='red'>-0.5%</font>.</li><li>Losers are widespread: <a href='https://seekingalpha.com/symbol/MRO' title='Marathon Oil Corporation'>MRO</a> <font color='red'>-4.4%</font>, <a href='https://seekingalpha.com/symbol/PBR' title='Petrobras - Petroleo Brasileiro S.A.'>PBR</a> <font color='red'>-3.6%</font>, <a href='https://seekingalpha.com/symbol/PXD' title='Pioneer Natural Resources Company'>PXD</a> <font color='red'>-3.1%</font>, <a href='https://seekingalpha.com/symbol/COP' title='ConocoPhillips'>COP</a> <font color='red'>-2.4%</font>, <a href='https://seekingalpha.com/symbol/KMI' title='Kinder Morgan, Inc.'>KMI</a> <font color='red'>-2.1%</font>, <a href='https://seekingalpha.com/symbol/APC' title='Anadarko Petroleum Corporation'>APC</a> <font color='red'>-1.9%</font>, <a href='https://seekingalpha.com/symbol/ENB' title='Enbridge Inc.'>ENB</a> <font color='red'>-1.8%</font>, <a href='https://seekingalpha.com/symbol/HES' title='Hess Corporation'>HES</a> <font color='red'>-1.7%</font>, <a href='https://seekingalpha.com/symbol/CXO' title='Concho Resources Inc.'>CXO</a> <font color='red'>-1.4%</font>, <a href='https://seekingalpha.com/symbol/EOG' title='EOG Resources, Inc.'>EOG</a> <font color='red'>-1.3%</font>, <a href='https://seekingalpha.com/symbol/OXY' title='Occidental Petroleum Corporation'>OXY</a> <font color='red'>-0.5%</font>.</li><li>Among refiners: <a href='https://seekingalpha.com/symbol/MPC' title='Marathon Petroleum Corp.'>MPC</a> <font color='red'>-2.3%</font>, <a href='https://seekingalpha.com/symbol/VLO' title='Valero Energy Corporation'>VLO</a> <font color='red'>-0.9%</font>, <a href='https://seekingalpha.com/symbol/PSX' title='Phillips 66'>PSX</a> <font color='red'>-0.6%</font>.</li><li>Among MLPs: <a href='https://seekingalpha.com/symbol/WMB' title='Williams Companies Inc'>WMB</a> <font color='red'>-2%</font>, <a href='https://seekingalpha.com/symbol/PAA' title='Plains All American Pipeline, L.P.'>PAA</a> <font color='red'>-1.7%</font>, ETP <font color='red'>-1.4%</font>, <a href='https://seekingalpha.com/symbol/EPD' title='Enterprise Products Partners L.P'>EPD</a> <font color='red'>-0.9%</font>, <a href='https://seekingalpha.com/symbol/MMP' title='Magellan Midstream Partners, L.P.'>MMP</a> <font color='red'>-0.2%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a>, <a href='https://seekingalpha.com/symbol/VDE' title='Vanguard Energy ETF'>VDE</a>, <a href='https://seekingalpha.com/symbol/ERX' title='Direxion Daily Energy Bull 3x Shares ETF'>ERX</a>, <a href='https://seekingalpha.com/symbol/OIH' title='VanEck Vectors Oil Services ETF'>OIH</a>, <a href='https://seekingalpha.com/symbol/XOP' title='SPDR S&P Oil & Gas Exploration & Production ETF'>XOP</a>, <a href='https://seekingalpha.com/symbol/FCG' title='First Trust Natural Gas ETF'>FCG</a>, <a href='https://seekingalpha.com/symbol/ERY' title='Direxion Daily Energy Bear 3x Shares ETF'>ERY</a>, <a href='https://seekingalpha.com/symbol/GASL' title='Direxion Daily Natural Gas Related Bull 3x Shares ETF'>GASL</a>, <a href='https://seekingalpha.com/symbol/DIG' title='ProShares Ultra Oil & Gas ETF'>DIG</a>, <a href='https://seekingalpha.com/symbol/DUG' title='ProShares UltraShort Oil & Gas ETF'>DUG</a>, <a href='https://seekingalpha.com/symbol/BGR' title='BlackRock Energy&Resources Trust'>BGR</a>, <a href='https://seekingalpha.com/symbol/XES' title='SPDR S&P Oil & Gas Equipment & Services ETF'>XES</a>, <a href='https://seekingalpha.com/symbol/IYE' title='iShares U.S. Energy ETF'>IYE</a>, <a href='https://seekingalpha.com/symbol/IEO' title='iShares U.S. Oil & Gas Exploration & Production ETF'>IEO</a>, <a href='https://seekingalpha.com/symbol/FENY' title='Fidelity MSCI Energy Index ETF'>FENY</a>, <a href='https://seekingalpha.com/symbol/IEZ' title='iShares U.S. Oil Equipment & Services ETF'>IEZ</a>, <a href='https://seekingalpha.com/symbol/PXE' title='Invesco Dynamic Energy Exploration & Production Portfolio ETF'>PXE</a>, <a href='https://seekingalpha.com/symbol/GASX' title='Direxion Daily Natural Gas Related Bear 3X Shares ETF'>GASX</a>, <a href='https://seekingalpha.com/symbol/PXI' title='Invesco DWA Energy Momentum Portfolio ETF'>PXI</a>, <a href='https://seekingalpha.com/symbol/FIF' title='First Trust Energy Infrastructure Fund'>FIF</a>, <a href='https://seekingalpha.com/symbol/PXJ' title='Invesco Dynamic Oil & Gas Services Portfolio ETF'>PXJ</a>, <a href='https://seekingalpha.com/symbol/RYE' title='Invesco S&P Equal Weight Energy ETF'>RYE</a>, <a href='https://seekingalpha.com/symbol/NDP' title='Tortoise Energy Independence Fund'>NDP</a>, <a href='https://seekingalpha.com/symbol/GUSH' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3x Shares ETF'>GUSH</a>, <a href='https://seekingalpha.com/symbol/PSCE' title='Invesco S&P SmallCap Energy Portfolio ETF'>PSCE</a>, <a href='https://seekingalpha.com/symbol/DRIP' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 3x Shares ETF'>DRIP</a>, <a href='https://seekingalpha.com/symbol/DDG' title='ProShares Short Oil & Gas ETF'>DDG</a>, <a href='https://seekingalpha.com/symbol/FXN' title='First Trust Energy AlphaDEX ETF'>FXN</a>, <a href='https://seekingalpha.com/symbol/CRAK' title='VanEck Vectors Oil Refiners ETF'>CRAK</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3251009\" data-linked=\"Energy drags averages lower, weighed by sinking crude oil\" data-tweet=\"$RDS.A $RDS.A $BP - Energy drags averages lower, weighed by sinking crude oil https://seekingalpha.com/news/3251009-energy-drags-averages-lower-weighed-sinking-crude-oil?source=tweet\" data-url=\"https://seekingalpha.com/news/3251009-energy-drags-averages-lower-weighed-sinking-crude-oil\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>59&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251006\" data-ts=\"1489509899\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RY\" target=\"_blank\">RY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251006-healthcare-stocks-under-water-gop-tries-to-advance-aca-replacement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare stocks under water as GOP tries to advance ACA replacement</a></h4><ul><li>Healthcare stocks are under pressure today as Republicans ares trying to <a href=\"http://www.reuters.com/article/us-usa-obamacare-idUSKBN16L1VF\" target=\"_blank\">deflect criticism</a> over their plan to dismantle the Affordable Care Act which, according to the Congressional Budget Office &#40;CBO&#41;, will cause 14M Americans to lose health insurance coverage.</li><li>The Trump administration is defending the plan, saying it offers consumers more choices. The President has yet to comment on the CBO report.</li><li>(<a href='https://seekingalpha.com/symbol/BIB' title='ProShares Ultra Nasdaq Biotechnology ETF'>BIB</a> <font color='red'>-1.7%</font>)(<a href='https://seekingalpha.com/symbol/IBB' title='iShares Nasdaq Biotechnology ETF'>IBB</a> <font color='red'>-0.7%</font>)(<a href='https://seekingalpha.com/symbol/GRX' title='The Gabelli Healthcare & Wellness Rx Trust'>GRX</a> <font color='red'>-0.4%</font>)(<a href='https://seekingalpha.com/symbol/BIS' title='ProShares UltraShort Nasdaq Biotechnology ETF'>BIS</a> <font color='green'>+1.7%</font>)(<a href='https://seekingalpha.com/symbol/RY' title='Royal Bank of Canada'>RY</a> <font color='red'>-0.3%</font>)(<a href='https://seekingalpha.com/symbol/BME' title='BlackRock Health Sciences Trust'>BME</a> <font color='green'>+0.3%</font>)(<a href='https://seekingalpha.com/symbol/CNCR' title='Loncar Cancer Immunotherapy ETF'>CNCR</a> <font color='red'>-1.8%</font>)(<a href='https://seekingalpha.com/symbol/THW' title='Tekla World Healthcare Fund'>THW</a> <font color='green'>+0.2%</font>)(<a href='https://seekingalpha.com/symbol/ARKG' title='ARK Genomic Revolution Multi-Sector ETF'>ARKG</a> <font color='red'>-0.5%</font>)(<a href='https://seekingalpha.com/symbol/GNRX' title='VanEck Vectors Generic Drugs ETF'>GNRX</a>)(<a href='https://seekingalpha.com/symbol/PJP' title='Invesco Dynamic Pharmaceuticals Portfolio ETF'>PJP</a> <font color='red'>-0.9%</font>)(<a href='https://seekingalpha.com/symbol/IHE' title='iShares U.S. Pharmaceuticals ETF'>IHE</a> <font color='red'>-0.9%</font>)(<a href='https://seekingalpha.com/symbol/XPH' title='SPDR S&P Pharmaceuticals ETF'>XPH</a> <font color='red'>-0.6%</font>)(<a href='https://seekingalpha.com/symbol/PPH' title='VanEck Vectors Pharmaceutical ETF'>PPH</a> <font color='red'>-0.3%</font>)(<a href='https://seekingalpha.com/symbol/XHS-OLD' title='SPDR S&P Health Care Services ETF'>XHS-OLD</a> <font color='red'>-1.1%</font>)(<a href='https://seekingalpha.com/symbol/IHI' title='iShares U.S. Medical Devices ETF'>IHI</a> <font color='red'>-0.9%</font>)(<a href='https://seekingalpha.com/symbol/XHE' title='SPDR S&P Health Care Equipment ETF'>XHE</a> <font color='red'>-0.8%</font>)</li><li>Sampling of affected tickers: (<a href='https://seekingalpha.com/symbol/CI' title='Cigna Corporation'>CI</a>)(<a href='https://seekingalpha.com/symbol/AET' title='Aetna, Inc.'>AET</a> <font color='red'>-0.8%</font>)(<a href='https://seekingalpha.com/symbol/CYH' title='Community Health Systems, Inc.'>CYH</a> <font color='red'>-2%</font>)(<a href='https://seekingalpha.com/symbol/HUM' title='Humana Inc.'>HUM</a> <font color='red'>-0.7%</font>)(<a href='https://seekingalpha.com/symbol/UNH' title='UnitedHealth Group Inc.'>UNH</a> <font color='red'>-0.8%</font>)(<a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a> <font color='red'>-5.1%</font>)(<a href='https://seekingalpha.com/symbol/HCA' title='HCA Holdings, Inc.'>HCA</a> <font color='red'>-1.8%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3251006\" data-linked=\"Healthcare stocks under water as GOP tries to advance ACA replacement\" data-tweet=\"$RY $BIB $IBB - Healthcare stocks under water as GOP tries to advance ACA replacement https://seekingalpha.com/news/3251006-healthcare-stocks-under-water-gop-tries-to-advance-aca-replacement?source=tweet\" data-url=\"https://seekingalpha.com/news/3251006-healthcare-stocks-under-water-gop-tries-to-advance-aca-replacement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>66&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3251002\" data-ts=\"1489508351\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PETX\" target=\"_blank\">PETX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3251002-aratana-q4-top-line-shy-of-consensus-shares-slump-21\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aratana Q4 top line shy of consensus; shares slump 21%</a></h4><ul><li>Aratana Therapeutics (<a href='https://seekingalpha.com/symbol/PETX' title='Aratana Therapeutics'>PETX</a> <font color='red'>-21.2%</font>) <a href=\"https://seekingalpha.com/pr/16769741-aratana-therapeutics-reports-fourth-quarter-full-year-2016-financial-results\" target=\"_blank\">Q4 results</a> ($M): Revenues: 0.3 (+363.5%). Consensus was 0.86.</li><li>Net Loss: (23.3) (-81.5%); Loss/Share: (0.64) (-72.8%).</li><li><strong>2017 Guidance</strong>: Quick assets will be sufficient to fund operations through Q1 2018.</li></ul><div class=\"tiny-share-widget\" data-id=\"3251002\" data-linked=\"Aratana Q4 top line shy of consensus; shares slump 21%\" data-tweet=\"$PETX - Aratana Q4 top line shy of consensus; shares slump 21% https://seekingalpha.com/news/3251002-aratana-q4-top-line-shy-of-consensus-shares-slump-21?source=tweet\" data-url=\"https://seekingalpha.com/news/3251002-aratana-q4-top-line-shy-of-consensus-shares-slump-21\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250999\" data-ts=\"1489507737\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIOC\" target=\"_blank\">BIOC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250999-catalyst-pharma-to-offer-biocepts-liquid-biopsy-test-in-late-stage-lems-study-shares-of-ahead\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Catalyst Pharma to offer Biocept&#39;s liquid biopsy test in late-stage LEMS study; shares of both ahead 3%</a></h4><ul><li>Biocept (<a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a> <font color='green'>+3.4%</font>) announces a <a href=\"https://seekingalpha.com/pr/16770331-biocept-catalyst-pharmaceuticals-collaborate-provide-liquid-biopsy-testing-small-cell-lung\" target=\"_blank\">collaboration </a>with Catalyst Pharmaceuticals (<a href='https://seekingalpha.com/symbol/CPRX' title='Catalyst Pharmaceuticals, Inc.'>CPRX</a> <font color='green'>+3.1%</font>) under which it will provide its Target Selector platform to screen participants in a Phase 3 study assessing Firdapse (amifampridine phosphate) in patients with Eaton Myasthenic Syndrome &#40;LEMS&#41;.</li><li>Specifically, Catalyst will offer the test at no charge to patients to monitor the early onset or recurrence of small cell lung cancer &#40;SCLC&#41; during the long-term extension phase of the trial. Subjects will have access to the liquid biopsy test every six months for up to two years.</li><li>About half of LEMS patients have a form of the disease that is associated with an increased risk of developing SCLC. Approximately 90% of these patients develop tumors within two years of the LEMS diagnosis.</li><li>Terms of the agreement are not disclosed.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3230827-enrollment-underway-catalyst-pharmas-second-late-stage-study-firdapse-lems\" target=\"_blank\">Enrollment underway in Catalyst Pharma's second late-stage study of Firdapse in LEMS</a> (Dec. 15, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3250999\" data-linked=\"Catalyst Pharma to offer Biocept&#39;s liquid biopsy test in late-stage LEMS study; shares of both ahead 3%\" data-tweet=\"$BIOC $BIOC $CPRX - Catalyst Pharma to offer Biocept&#39;s liquid biopsy test in late-stage LEMS study; shares of both ahead 3% https://seekingalpha.com/news/3250999-catalyst-pharma-to-offer-biocepts-liquid-biopsy-test-in-late-stage-lems-study-shares-of-ahead?source=tweet\" data-url=\"https://seekingalpha.com/news/3250999-catalyst-pharma-to-offer-biocepts-liquid-biopsy-test-in-late-stage-lems-study-shares-of-ahead\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250995\" data-ts=\"1489507114\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CIE\" target=\"_blank\">CIE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250995-cobalt-energyminus-15-on-wider-expected-q4-loss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cobalt Energy -15% on wider than expected Q4 loss</a></h4><ul>     <li>Cobalt Energy (<a href='https://seekingalpha.com/symbol/CIE' title='Cobalt International Energy, Inc.'>CIE</a> <font color='red'>-14.8</font>) plunges to 52-week lows after reporting a <a href=\"https://seekingalpha.com/news/3250849-cobalt-international-energy-eps-4_47\" target=\"_blank\">Q4 loss</a> of $0.43/share, excluding $4.04 in non-recurring items, $0.28 worse than the analyst consensus estimate of a $0.15 loss.</li>     <li>CIE says its North Platte #4 appraisal well in the deepwater Gulf of Mexico encountered ~650 ft. of net oil pay, with initial results indicating high quality reservoirs on the field's eastern flank of the field; appraisal operations continue at North Platte, where CIE  recently completed drilling of the North Platte #4 sidetrack well to further analyze the extent of the eastern flank.</li>     <li>For 2017, CIE forecasts $275M in capex, cash outlays of $550M-$650M and $50M in net revenue.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250995\" data-linked=\"Cobalt Energy -15% on wider than expected Q4 loss\" data-tweet=\"$CIE - Cobalt Energy -15% on wider than expected Q4 loss https://seekingalpha.com/news/3250995-cobalt-energyminus-15-on-wider-expected-q4-loss?source=tweet\" data-url=\"https://seekingalpha.com/news/3250995-cobalt-energyminus-15-on-wider-expected-q4-loss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250990\" data-ts=\"1489506337\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TECK\" target=\"_blank\">TECK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250990-teck-resources-may-to-gain-zinc-refiners-squeezed\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teck Resources may have most to gain if zinc refiners squeezed</a></h4><ul>     <li>Teck Resources (<a href='https://seekingalpha.com/symbol/TECK' title='Teck Resources Limited'>TECK</a> <font color='red'>-1.7%</font>) <a href=\"https://www.bloomberg.com/news/articles/2017-03-14/why-teck-may-have-the-most-to-gain-if-zinc-refiners-are-squeezed\" target=\"_blank\">could gain the most of any mining company</a> if a supply shortfall in zinc forces smelters to cut the fees they charge miners to refine the metal, Bloomberg reports.</li>     <li>Should talks between miners and smelters result in lower processing fees,&nbsp;Teck stands to benefit from its surplus in unprocessed ore, and that gain would come in addition to the tailwind the company already enjoys from  higher prices for zinc and the other commodities it sells.</li><li>Teck CEO&nbsp;Don Lindsay says talks to set benchmark processing fees this year are likely to result in  the &ldquo;largest decrease in treatment charges in modern history.&rdquo;</li> </ul><div class=\"tiny-share-widget\" data-id=\"3250990\" data-linked=\"Teck Resources may have most to gain if zinc refiners squeezed\" data-tweet=\"$TECK - Teck Resources may have most to gain if zinc refiners squeezed https://seekingalpha.com/news/3250990-teck-resources-may-to-gain-zinc-refiners-squeezed?source=tweet\" data-url=\"https://seekingalpha.com/news/3250990-teck-resources-may-to-gain-zinc-refiners-squeezed\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250993\" data-ts=\"1489506335\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250993-healthcare-top-5-gainers-losers-of-11-45-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:45 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/NVCN' title='Neovasc Inc.'>NVCN</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/EDIT' title='Editas Medicine'>EDIT</a> <font color='green'>+11%</font>. NVLS <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/SBOT' title='Stellar Biotechnologies Inc.'>SBOT</a> <font color='green'>+9%</font>. ETRM <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ADPT' title='Adeptus Health'>ADPT</a> <font color='red'>-29%</font>. <a href='https://seekingalpha.com/symbol/AUPH' title='Aurinia Pharmaceuticals Inc.'>AUPH</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/PETX' title='Aratana Therapeutics'>PETX</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/INNL' title='Innocoll'>INNL</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/ARLZ-OLD' title='Aralez Pharmaceuticals Inc.'>ARLZ-OLD</a> <font color='red'>-14%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250993\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:45 PM\" data-tweet=\"$NVCN $EDIT $ALPN - Healthcare - Top 5 Gainers / Losers as of 11:45 PM https://seekingalpha.com/news/3250993-healthcare-top-5-gainers-losers-of-11-45-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3250993-healthcare-top-5-gainers-losers-of-11-45-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250989\" data-ts=\"1489506078\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REPCF\" target=\"_blank\">REPCF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250989-replicels-autologous-cell-therapy-candidate-to-treat-hair-loss-safe-in-long-term-study-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RepliCel&#39;s autologous cell therapy candidate to treat hair loss safe in long-term study; shares ease 5% on long development timeline</a></h4><ul><li>Thinly traded nano cap ReliCel Life Sciences (<a href='https://seekingalpha.com/symbol/REPCF' title='RepliCel Life Sciences Inc.'>OTCQB:REPCF</a> <font color='red'>-5.1%</font>) &nbsp;slips after it <a href=\"https://seekingalpha.com/pr/16770048-replicels-phase-1-clinical-trial-hair-loss-succeeds-meeting-primary-endpoints\" target=\"_blank\">announced </a>data from a five-year Phase 1 study assessing the safety of its autologous cell therapy for the treatment of androgenic alopecia (pattern baldness), <a href=\"http://replicel.com/product-pipeline/rch-01-hair-regeneration/\" target=\"_blank\">RCH-01</a>. The results were fine, but the timeline for the next study has apparently dampened investors' enthusiasm.</li><li>The 19-subject trial met its endpoints thereby confirming the complete safety profile of a high dose of dermal sheath cup cells, administered via injection, for patients with pattern baldness.</li><li>Although not powered for efficacy, a treatment effect was observed. The seven best responders experienced at least a 10% increase versus baseline in hair density six months after injection. At month 24, the average hair density increase in the same seven subjects was 8.3%. The top responder showed a 21% increase in hair density at month 24.</li><li>The company intends to advance RCH-01 into a Phase 2 study in 160 healthy men with mild-to-moderate pattern baldness. Dermal sheath cup cells will be isolated from a small punch biopsy taken from the back of the subject's scalp. The cells will be replicated and then reintroduced into balding areas. Participants will remain on study for ~39 months.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250989\" data-linked=\"RepliCel&#39;s autologous cell therapy candidate to treat hair loss safe in long-term study; shares ease 5% on long development timeline\" data-tweet=\"$REPCF - RepliCel&#39;s autologous cell therapy candidate to treat hair loss safe in long-term study; shares ease 5% on long development timeline https://seekingalpha.com/news/3250989-replicels-autologous-cell-therapy-candidate-to-treat-hair-loss-safe-in-long-term-study-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3250989-replicels-autologous-cell-therapy-candidate-to-treat-hair-loss-safe-in-long-term-study-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250986\" data-ts=\"1489505016\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XAN\" target=\"_blank\">XAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250986-resource-capitalplus-6-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Resource Capital +6% after earnings</a></h4><ul><li>Q4 core loss of $3.7M or $0.12 per share; full-year core loss of $1M and $0.03. Q4 dividend was $0.05.</li><li>Dec. 31 book value per share of $14.17 vs. $14.71 in Q3, and down from $17.63 a year earlier. Current price after today's gain is $8.61.</li><li>New loans originated during quarter of $50.6M; after payoffs and principal paydowns, net loans down $9.1M for quarter and $116.3M for year.</li><li><a href=\"https://seekingalpha.com/article/4054926-resource-capitals-rso-ceo-robert-lieber-q4-2016-results-earnings-call-transcript?part=single\" target=\"_blank\">Earnings call transcript</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3250814-resource-capital-beats-0_34-beats-revenue\" target=\"_blank\">Resource Capital beats by $0.34, beats on revenue</a> (March 14)</li><li>RSO&nbsp;<font color='green'>+5.8%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3250986\" data-linked=\"Resource Capital +6% after earnings\" data-tweet=\"$XAN - Resource Capital +6% after earnings https://seekingalpha.com/news/3250986-resource-capitalplus-6-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3250986-resource-capitalplus-6-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250985\" data-ts=\"1489504998\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GXYEF\" target=\"_blank\">GXYEF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250985-double-digit-revenue-growth-expected-in-macau-this-month\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Double-digit revenue growth expected in Macau this month</a></h4><ul> <li>Hong Kong-traded Macau names moved higher today after JPMorgan issued a positive forecast on Macau revenue trends for March.</li> <li>JP says the VIP segment is tracking at a high teens growth rate and the mass market segment is up at a low-to-mid teens growth pace. \"This would make first-quarter GGR grow 11 percent to 12 percent year-on-year and 3 percent to 4 percent quarter-on-quarter, to the highest level in eight quarters: the sector&rsquo;s sequential profit expansion story remains intact, in our view,\" reads the analyst note.</li> <li>Estimates for March Macau revenue range from <a href=\"http://www.ggrasia.com/macau-tracking-9pct-plus-ggr-growth-march-analysts/\" target=\"_blank\">9% to 15%</a>, according to GGRAsia.</li> <li>Hong Kong: Wynn Macau<font color='green'> +3.34%</font>, MGM China <font color='green'>+2.01%</font>, Sands China <font color='green'>+1.92%</font>, Galaxy Entertainment (<a href='https://seekingalpha.com/symbol/GXYEF' title='Galaxy Entertainment Group, Ltd.'>OTCPK:GXYEF</a>) <font color='green'>+2.07%</font>.</li> <li>New York: Wynn Resorts (<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a> <font color='green'>+0.1%</font>), MGm Resorts (<a href='https://seekingalpha.com/symbol/MGM' title='MGM Resorts International'>MGM</a> <font color='green'>+0.7%</font>), Las Vegas Sands (<a href='https://seekingalpha.com/symbol/LVS' title='Las Vegas Sands Corp.'>LVS</a> <font color='green'>+0.5%</font>), Melco Crown (MPEL <font color='green'>+3.2%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3250985\" data-linked=\"Double-digit revenue growth expected in Macau this month\" data-tweet=\"$GXYEF $GXYEF $WYNN - Double-digit revenue growth expected in Macau this month https://seekingalpha.com/news/3250985-double-digit-revenue-growth-expected-in-macau-this-month?source=tweet\" data-url=\"https://seekingalpha.com/news/3250985-double-digit-revenue-growth-expected-in-macau-this-month\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250978\" data-ts=\"1489503618\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HBAYF\" target=\"_blank\">HBAYF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250978-hudsons-bay-takes-aim-neiman-marcus-wsj\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hudson&#39;s Bay takes aim at Neiman Marcus - WSJ</a></h4><ul> <li>Hudson's Bay (<a href='https://seekingalpha.com/symbol/HBAYF' title='Hudson&#39;s Bay Co'>OTCPK:HBAYF</a>) is <a href=\"https://www.wsj.com/articles/neiman-marcus-hires-advisers-to-explore-strategic-alternatives-1489499472\" target=\"_blank\">in talks</a> to buy Neiman Marcus (NYSE:<a href='https://seekingalpha.com/symbol/NM' title='Navios Maritime Holdings Inc.'>NM</a>) from its private equity owners, sources tell The Wall Street Journal.</li> <li>The department store chain is believed to want a deal that doesn't include an assumption of debt.</li> <li>Neiman Marcus backers Ares Management and Canada Pension Plan Investment Board pulled plans for a Neiman Marcus IPO earlier this year.</li> <li>Macy's (<a href='https://seekingalpha.com/symbol/M' title='Macy&#39;s Inc.'>M</a> <font color='red'>-0.5%</font>) is slightly lower on the day. It has already been reported that Hudson's was taking a pass on a Macy's acquisition.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3248532-hudsons-bay-said-struggle-financing-macys-bid\" target=\"_blank\">Hudson's Bay said to struggle on financing a Macy's bid</a> (March 3)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3248745-hopes-fade-hudsons-bay-buyout-macys\" target=\"_blank\">Hopes fade for a Hudson's Bay buyout of Macy's</a> (March 6)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3250978\" data-linked=\"Hudson&#39;s Bay takes aim at Neiman Marcus - WSJ\" data-tweet=\"$HBAYF $HBAYF $NM - Hudson&#39;s Bay takes aim at Neiman Marcus - WSJ https://seekingalpha.com/news/3250978-hudsons-bay-takes-aim-neiman-marcus-wsj?source=tweet\" data-url=\"https://seekingalpha.com/news/3250978-hudsons-bay-takes-aim-neiman-marcus-wsj\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250977\" data-ts=\"1489503165\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PAY\" target=\"_blank\">PAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250977-payments-sector-m-shakeup-in-works\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Payments sector M&amp;A shakeup in the works</a></h4><ul> <li>Shares of VeriFone Systems (<a href='https://seekingalpha.com/symbol/PAY' title='VeriFone Systems, Inc.'>PAY</a> <font color='green'>+0.6%</font>) are active after DealReporter tips that Ant Financial (NYSE:<a href='https://seekingalpha.com/symbol/BABA' title='Alibaba Group Holding Limited'>BABA</a>) may jump in as a buyer if its pursuit of Moneygram goes astray.</li> <li>Earlier today, Euronet Worldwide (<a href='https://seekingalpha.com/symbol/EEFT' title='Euronet Worldwide, Inc.'>EEFT</a> <font color='green'>+0.4%</font>)&nbsp;made a strong offer for Moneygram (<a href='https://seekingalpha.com/symbol/MGI' title='MoneyGram International, Inc.'>MGI</a> <font color='green'>+25.3%</font>) at $15.20 per share vs. Ant's $13.25.</li><li>SunTrust called the Euronet-Moneygram combination a good fit in its quick analysis of the payments sector shakeup (via Bloomberg).</li> <li>Also keep an eye on Western Union (<a href='https://seekingalpha.com/symbol/WU' title='The Western Union Company'>WU</a> <font color='green'>+4.4%</font>), which is frequently in the payments M&amp;A rumor mill.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3250862-euronet-worldwide-makes-run-moneygram\" target=\"_blank\">Euronet Worldwide makes a run for Moneygram</a> (March 14)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3250977\" data-linked=\"Payments sector M&amp;A shakeup in the works\" data-tweet=\"$PAY $PAY $BABA - Payments sector M&amp;A shakeup in the works https://seekingalpha.com/news/3250977-payments-sector-m-shakeup-in-works?source=tweet\" data-url=\"https://seekingalpha.com/news/3250977-payments-sector-m-shakeup-in-works\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250973\" data-ts=\"1489502552\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DHCP\" target=\"_blank\">DHCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250973-walter-investment-plunges-37-after-rough-quarter-disclosures\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Walter Investment plunges 37% after rough quarter, disclosures</a></h4><ul><li>Cutting costs while deleveraging the balance sheet is more difficult than anticipated, says Compass Point's Fred Small, taking note of a 42% Q/Q decline in originations segment earnings. Regulatory issues in reverse mortgages remain, and then there's the HUD investigation and material weakness in the Ditech unit.</li><li>If there's a sliver lining to Q4 results, says Small, it's an increase in tangible book value.</li><li>Source: Bloomberg</li><li>Previously: <a href=\"https://seekingalpha.com/news/3250879-walter-investment-posts-big-q4-loss\" target=\"_blank\">Walter Investment posts big Q4 loss</a> (March 14)</li><li>WAC&nbsp;<font color='red'>-37%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3250973\" data-linked=\"Walter Investment plunges 37% after rough quarter, disclosures\" data-tweet=\"$DHCP - Walter Investment plunges 37% after rough quarter, disclosures https://seekingalpha.com/news/3250973-walter-investment-plunges-37-after-rough-quarter-disclosures?source=tweet\" data-url=\"https://seekingalpha.com/news/3250973-walter-investment-plunges-37-after-rough-quarter-disclosures\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250967\" data-ts=\"1489502107\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHK\" target=\"_blank\">CHK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250967-two-chesapeake-directors-bought-12m-in-shares-this-month\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Two Chesapeake directors bought $12M in shares this month</a></h4><ul>     <li>Two Chesapeake Energy (<a href='https://seekingalpha.com/symbol/CHK' title='Chesapeake Energy Corporation'>CHK</a> <font color='red'>-4.8%</font>) directors <a href=\"http://www.barrons.com/articles/chesapeake-directors-buy-stock-despite-everything-1489494667\" target=\"_blank\">recently bought nearly $12M in shares</a> on the open market, as the company's stock has dropped 21% in the past month.</li>     <li>Chairman Emeritus Archie Dunham last week bought ~500K shares for $2.6M, or $5.24 each on average, after paying more than $11.4M for 1.85M shares since August; he now owns more than 4.6M shares, far more than anyone else.</li>     <li>Director Thomas Ryan has bought 100K more CHK shares for ~$550K, most recently purchasing 50K shares on March 3, and now owns 314K shares.</li>     <li>Dunham and Ryan are the only CHK insiders to buy the stock in 2016 and so far this year, and they have been punished for their optimism; Dunham&rsquo;s recent purchases are in the red by more than $1.5M through Monday&rsquo;s close, and Ryan has lost more than $500K on shares purchased since August.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250967\" data-linked=\"Two Chesapeake directors bought $12M in shares this month\" data-tweet=\"$CHK - Two Chesapeake directors bought $12M in shares this month https://seekingalpha.com/news/3250967-two-chesapeake-directors-bought-12m-in-shares-this-month?source=tweet\" data-url=\"https://seekingalpha.com/news/3250967-two-chesapeake-directors-bought-12m-in-shares-this-month\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250966\" data-ts=\"1489502010\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EWQ\" target=\"_blank\">EWQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250966-france-heads-bit-lower-fillon-charged\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">France heads a bit lower as Fillon charged</a></h4><ul><li>Republican candidate Francois Fillon has reportedly been charged with misuse of public funds. He's currently third in first-round presidential polling with about 20% support. Marine Le Pen is in the lead with 27%.</li><li>The CAC 40 is<font color='red'> lower by 0.7%</font>. <a href='https://seekingalpha.com/symbol/EWQ' title='iShares MSCI France ETF'>EWQ</a>&nbsp;<font color='red'>-1.05%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3250966\" data-linked=\"France heads a bit lower as Fillon charged\" data-tweet=\"$EWQ - France heads a bit lower as Fillon charged https://seekingalpha.com/news/3250966-france-heads-bit-lower-fillon-charged?source=tweet\" data-url=\"https://seekingalpha.com/news/3250966-france-heads-bit-lower-fillon-charged\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250965\" data-ts=\"1489501711\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTB\" target=\"_blank\">CTB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250965-52-week-high-for-cooper-tire-rubber-after-jpmorgan-nod\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">52-week high for Cooper Tire &amp; Rubber after JPMorgan nod</a></h4><ul> <li>Cooper Tire &amp; Rubber (<a href='https://seekingalpha.com/symbol/CTB' title='Cooper Tire & Rubber Co.'>CTB</a> <font color='green'>+4.3%</font>) breaks higher after JPMorgan <a href=\"https://twitter.com/usratings/status/841654674138767360\" target=\"_blank\">upgrades</a> the tire stock to Overweight from Neutral.</li> <li>Analyst Ryan Brinkman points to the promise of Cooper's long-term margins to improve over what investors expect.</li> <li>JP's price target on Cooper goes to $51 from $47.</li> <li>Shares of Cooper carved out a new 52-week high of $43.85.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3250965\" data-linked=\"52-week high for Cooper Tire &amp; Rubber after JPMorgan nod\" data-tweet=\"$CTB - 52-week high for Cooper Tire &amp; Rubber after JPMorgan nod https://seekingalpha.com/news/3250965-52-week-high-for-cooper-tire-rubber-after-jpmorgan-nod?source=tweet\" data-url=\"https://seekingalpha.com/news/3250965-52-week-high-for-cooper-tire-rubber-after-jpmorgan-nod\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250964\" data-ts=\"1489501576\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GALT\" target=\"_blank\">GALT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250964-galectin-reports-positive-preliminary-results-in-small-study-of-gr-mdminus-02-in-treatment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Galectin reports positive preliminary results in small study of GR-MD-02 in treatment-resistant eczema; shares ahead 2%</a></h4><ul><li>Galectin Therapeutics (<a href='https://seekingalpha.com/symbol/GALT' title='Galectin Therapeutics, Inc.'>GALT</a> <font color='green'>+2.2%</font>) is steadily clawing its way back from a Q4 plunge after lead product candidate GR-MD-02 flunked a mid-stage NASH study. Investors have warmed to the sock after the product candidate showed potential in severe skin disorders like plaque psoriasis. Shares have almost doubled since late January.</li><li>Today, the company <a href=\"https://seekingalpha.com/pr/16770457-gr-mdminus-02-demonstrates-clinically-significant-effect-patients-severe-refractory-atopic\" target=\"_blank\">announced </a>encouraging early results from a small, open-label, investigator-initiated study of GR-MD-02 in three patients with severe and refractory atopic dermatitis &#40;AD&#41;. All three responded to therapy, with two achieving 64% and 74% reductions, respectively, in a measure of AD symptoms called EASI score.</li><li>CEO Peter G. Traber, M.D. says, &ldquo;We are pleased by the results of this study demonstrating the safety and clinically significant effect in patients with severe atopic dermatitis, although because of the potential of a placebo effect in this disease, confirmation of the magnitude of the effect will require placebo-controlled trials. Moreover, the activity of GR-MD-02 in these patients compares favorably with other drugs currently in development, and with minimal side effects as demonstrated by nearly 3,000 doses of our compound being administered in multiple completed and ongoing clinical trials with no severe adverse effects attributed to the drug.&rdquo;</li><li><a href=\"http://galectintherapeutics.com/what-we-do/develop-proprietary-compounds-for-disease/development-program/\" target=\"_blank\">GR-MD-02</a>&nbsp;is a complex carbohydrate drug that targets&nbsp;<a href=\"https://en.wikipedia.org/wiki/Galectin-3\" target=\"_blank\">galectin-3</a>, a protein that plays a key role in the pathogenesis of fatty liver disease and fibrosis.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250964\" data-linked=\"Galectin reports positive preliminary results in small study of GR-MD-02 in treatment-resistant eczema; shares ahead 2%\" data-tweet=\"$GALT - Galectin reports positive preliminary results in small study of GR-MD-02 in treatment-resistant eczema; shares ahead 2% https://seekingalpha.com/news/3250964-galectin-reports-positive-preliminary-results-in-small-study-of-gr-mdminus-02-in-treatment?source=tweet\" data-url=\"https://seekingalpha.com/news/3250964-galectin-reports-positive-preliminary-results-in-small-study-of-gr-mdminus-02-in-treatment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250963\" data-ts=\"1489501304\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALSK\" target=\"_blank\">ALSK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250963-alaska-communicationsplus-4_3-q4-beats-on-top-bottom-lines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alaska Communications +4.3% as Q4 beats on top, bottom lines</a></h4><ul>   <li>Alaska Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/ALSK' title='Alaska Communications Systems Group, Inc.'>ALSK</a>) has <font color='green'>jumped 4.3%</font> after beating sales and profit expectations in <a href=\"https://seekingalpha.com/news/3250917-alaska-communications-reports-q4-results\" target=\"_blank\">Q4 results</a> this morning.</li>    <li>Net income grew to $1.6M vs. a year-ago $0.3M. Overall wireline revenues rose 2.1% and total broadband revenue was up 8.3% to $30.1M.</li>    <li>Net cash from operations was $8.8M vs. the previous $7.1M.</li>    <li>Revenue breakout: Business and wholesale, $35.4M (up 4.6%); Consumer, $9.4M (down 3.3%); Regulatory, $13M (down 0.5%).</li><li>The company set a <a href=\"https://seekingalpha.com/pr/16770459-alaska-communications-announces-10-million-share-repurchase-program-authorization\" target=\"_blank\">$10M buyback program</a>.</li>    <li>For 2017, it's guiding to wireline revenue of $229M-$235M, EBITDA of $59M-$61M, and capex of $35M-$38M. It expects to forecast free cash flow on its conference call after completing a tender for convertible debt.</li>    <li><a href=\"http://edge.media-server.com/m/p/hi5ipkvs\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/16770465-alaska-communications-reports-solid-fourth-quarter-year-end-2016-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3250963\" data-linked=\"Alaska Communications +4.3% as Q4 beats on top, bottom lines\" data-tweet=\"$ALSK - Alaska Communications +4.3% as Q4 beats on top, bottom lines https://seekingalpha.com/news/3250963-alaska-communicationsplus-4_3-q4-beats-on-top-bottom-lines?source=tweet\" data-url=\"https://seekingalpha.com/news/3250963-alaska-communicationsplus-4_3-q4-beats-on-top-bottom-lines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250961\" data-ts=\"1489500933\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NDLS\" target=\"_blank\">NDLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250961-noodles-flies-after-announcing-private-placement-financing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Noodles flies after announcing private placement financing</a></h4><ul>     <li>Noodles (<a href='https://seekingalpha.com/symbol/NDLS' title='Noodles & Company'>NDLS</a> <font color='green'>+11.8%</font>)&nbsp;announces a $31.5M private placement of class A common stock to Mill Road Capital II.</li>  <li>Under the terms of the arrangement, Mill Road receives 8.873M shares at a price per share of $3.55.</li>     <li>The company says the investment will help it strengthen its balance sheet and fund strategic initiatives.</li>     <li>Noodles no longer intends to pursue a public offering of its class A shares.</li>     <li>The transaction is expected to close in early April.</li>     <li>&ldquo;We are excited to announce this investment by Mill Road Capital, which has a strong record of investments in consumer brands, including in the restaurant industry,&rdquo; says interim CEO Dave Boennighausen.</li>     <li>Source: <a href=\"https://seekingalpha.com/pr/16770403-noodles-and-company-announces-private-placement-financing\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3250961\" data-linked=\"Noodles flies after announcing private placement financing\" data-tweet=\"$NDLS - Noodles flies after announcing private placement financing https://seekingalpha.com/news/3250961-noodles-flies-after-announcing-private-placement-financing?source=tweet\" data-url=\"https://seekingalpha.com/news/3250961-noodles-flies-after-announcing-private-placement-financing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250950\" data-ts=\"1489499944\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LCUT\" target=\"_blank\">LCUT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250950-lifetime-brands-52-week-high-after-earnings-buyout-offer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lifetime Brands at 52-week high after earnings, buyout offer</a></h4><ul> <li>Lifetime Brands (NASDAQ:<a href='https://seekingalpha.com/symbol/LCUT' title='Lifetime Brands, Inc.'>LCUT</a>) is <font color='green'>up 7.14%</font> to $20.25 after running up a 30% gain yesterday following earnings.</li> <li>Earlier today, the company landed a buyout offer from Mill Road at $20 per share. The board hasn't issued any <a href=\"http://phx.corporate-ir.net/phoenix.zhtml?c=74141&amp;p=irol-news&amp;nyo=0\" target=\"_blank\">response</a> to the overture yet.</li> <li>Shares of LCUT hit a 52-week high of $21.20 amid the buying frenzy.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3250548-lifetime-brands-beats-0_33-beats-revenue\" target=\"_blank\">Lifetime Brands beats by $0.33, beats on revenue</a> (March 13)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3250854-mill-road-capital-offers-buy-lifetime-brands\" target=\"_blank\">Mill Road Capital offers to buy Lifetime Brands</a> (March 14)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3250950\" data-linked=\"Lifetime Brands at 52-week high after earnings, buyout offer\" data-tweet=\"$LCUT - Lifetime Brands at 52-week high after earnings, buyout offer https://seekingalpha.com/news/3250950-lifetime-brands-52-week-high-after-earnings-buyout-offer?source=tweet\" data-url=\"https://seekingalpha.com/news/3250950-lifetime-brands-52-week-high-after-earnings-buyout-offer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250942\" data-ts=\"1489498981\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLYS\" target=\"_blank\">TLYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250942-tillys-spirals-lower-after-weak-guidanceminus-30-ytd\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tilly&#39;s spirals lower after weak guidance; -30% YTD</a></h4><ul> <li>Tilly's (<a href='https://seekingalpha.com/symbol/TLYS' title='Tilly&#39;s, Inc.'>TLYS</a> <font color='red'>-8.7%</font>) falls sharply after issuing Q1 guidance below the expectation of analysts.</li> <li>The company expects same-store sales to fall in at a low to mid-single-digit rate, contributing to a loss of $0.07 to $0.15 per share vs. +$0.04 consensus.</li> <li>During Q4, e-commerce sales were up 6.6% to represent 16.5% of sales, but weak store traffic dragged on total sales numbers. Product margins were down in the quarter due to a higher level of markdowns.</li> <li>On the conference call (<a href=\"https://seekingalpha.com/article/4054754-tillys-tlys-ceo-ed-thomas-q4-2016-results-earnings-call-transcript\" target=\"_blank\">transcript</a>), execs with Tilly's said they will be looking closely at 49 store leases either expiring or due for \"kick-outs.\"</li><li>Previously: <a href=\"https://seekingalpha.com/news/3250737-tillys-beats-0_01-beats-revenue\" target=\"_blank\">Tilly's beats by $0.01, beats on revenue</a> (March 13)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3250760-tillys-10-percent-dour-outlook\" target=\"_blank\">Tilly's down 10% after dour outlook</a> (March 13)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3250942\" data-linked=\"Tilly&#39;s spirals lower after weak guidance; -30% YTD\" data-tweet=\"$TLYS - Tilly&#39;s spirals lower after weak guidance; -30% YTD https://seekingalpha.com/news/3250942-tillys-spirals-lower-after-weak-guidanceminus-30-ytd?source=tweet\" data-url=\"https://seekingalpha.com/news/3250942-tillys-spirals-lower-after-weak-guidanceminus-30-ytd\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250934\" data-ts=\"1489497329\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250934-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul> <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/DRWI' title='DragonWave Inc.'>DRWI</a> <font color='green'>+48%</font>. <a href='https://seekingalpha.com/symbol/MGI' title='MoneyGram International, Inc.'>MGI</a> <font color='green'>+27%</font>. ETRM <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/RT' title='Ruby Tuesday, Inc.'>RT</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/RLJE' title='RLJ Entertainment, Inc.'>RLJE</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/EDIT' title='Editas Medicine'>EDIT</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/GALT' title='Galectin Therapeutics, Inc.'>GALT</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/NAKD' title='Naked Brand Group Limited'>NAKD</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/GOGL' title='Golden Ocean Group Limited'>GOGL</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/YY' title='YY Inc.'>YY</a> <font color='green'>+6%</font>.</li> <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ADPT' title='Adeptus Health'>ADPT</a> <font color='red'>-29%</font>. <a href='https://seekingalpha.com/symbol/AUPH' title='Aurinia Pharmaceuticals Inc.'>AUPH</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/PN' title='Patriot National, Inc.'>PN</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/INNL' title='Innocoll'>INNL</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/LNTH' title='Lantheus Holdings'>LNTH</a> <font color='red'>-12%</font>. CERU <font color='red'>-11%</font>. VRX <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/KNDI' title='Kandi Technologies Group, Inc.'>KNDI</a> <font color='red'>-10%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3250934\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$DRWI $MGI $RSLS - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/3250934-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3250934-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250926\" data-ts=\"1489497267\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMPH\" target=\"_blank\">AMPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250926-amphastar-q4-top-line-down-17-earnings-down-136-shares-off-75-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amphastar Q4 top line down 17%; earnings down 136%; shares off 75 premarket</a></h4><ul><li>Amphastar Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AMPH' title='Amphastar'>AMPH</a>) <a href=\"https://seekingalpha.com/pr/16769737-amphastar-pharmaceuticals-reports-financial-results-three-months-fiscal-year-ended-december\" target=\"_blank\">Q4 results</a> ($M): Revenues: 63.5 (-17.4%); Enoxaparin Sales: 8.3 (-58.3%).</li><li>Net Loss: (2.7) (-136.4%); Non-GAAP Net Income: 0.5 (-93.9%); Loss/Share: (0.06) (-50.0%); Non-GAAP EPS: 0.01 (-94.7%).</li><li>Anoxaparin sales down due to lower unit volumes in retail space after termination of distribution agreement with Actavis.</li><li>No guidance provided.</li><li>Shares are down&nbsp;<font color='red'>7%</font>&nbsp;premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250926\" data-linked=\"Amphastar Q4 top line down 17%; earnings down 136%; shares off 75 premarket\" data-tweet=\"$AMPH - Amphastar Q4 top line down 17%; earnings down 136%; shares off 75 premarket https://seekingalpha.com/news/3250926-amphastar-q4-top-line-down-17-earnings-down-136-shares-off-75-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3250926-amphastar-q4-top-line-down-17-earnings-down-136-shares-off-75-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250925\" data-ts=\"1489496751\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EDIT\" target=\"_blank\">EDIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250925-editas-inks-deal-allergan-for-many-five-gene-editing-ocular-programs-shares-ahead-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Editas inks deal with Allergan for as many as five gene-editing ocular programs; shares ahead 10% premarket</a></h4><ul><li>Gene-editing outfit Editas Medicine (NASDAQ:<a href='https://seekingalpha.com/symbol/EDIT' title='Editas Medicine'>EDIT</a>) jumps&nbsp;<font color='green'>10%&nbsp;</font>premarket on average volume in response to its <a href=\"https://seekingalpha.com/pr/16770245-allergan-editas-medicine-enter-strategic-r-and-d-alliance-discover-develop-crispr-genome\" target=\"_blank\">announcement </a>that it has entered into an exclusive R&amp;D alliance with Allergan (NYSE:<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a>) that provides the latter with an option to license up to five of EDIT's genome-editing ocular programs, including its lead program for Leber Congenital Amaurosis (LCA10), currently in preclinical development.</li><li>The agreement includes programs based on the CRISPR/Cas9 platform as well as CRISPR/Cpf1.</li><li>Under the terms of the deal, Editas will receive an upfront payment of $90M, milestones and sales-based royalties. Allergan will be responsible for development and commercialization of the optioned products, subject to EDIT's option to co-develop and co-promote up to two optioned products in the U.S.</li><li>Editas management will host a conference call today at 4:30 pm ET to discuss the alliance.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250925\" data-linked=\"Editas inks deal with Allergan for as many as five gene-editing ocular programs; shares ahead 10% premarket\" data-tweet=\"$EDIT $EDIT $AGN - Editas inks deal with Allergan for as many as five gene-editing ocular programs; shares ahead 10% premarket https://seekingalpha.com/news/3250925-editas-inks-deal-allergan-for-many-five-gene-editing-ocular-programs-shares-ahead-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3250925-editas-inks-deal-allergan-for-many-five-gene-editing-ocular-programs-shares-ahead-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250908\" data-ts=\"1489495364\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBR\" target=\"_blank\">CBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250908-ciber-confirms-0_75-share-takeover-offer-from-ameri-holdings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ciber confirms $0.75/share takeover offer from Ameri Holdings</a></h4><ul><li>Ciber (NYSE:<a href='https://seekingalpha.com/symbol/CBR' title='CIBER, Inc.'>CBR</a>) <font color='green'>+10.2%</font> premarket after confirming receipt of a non-binding <a href=\"https://seekingalpha.com/pr/16769908-ciber-issues-statement-commenting-unsolicited-offer-ameri-holdings\" target=\"_blank\">letter of interest</a> from Ameri Holdings to acquire the company for $0.75/share.</li><li>CBR shares more than doubled yesterday after Ameri announced its proposal consisting of a combination of cash, stock of the new company  and preferred stock.</li><li>Ameri already owns ~4.5M CBR shares, or 5.5% of shares outstanding.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250908\" data-linked=\"Ciber confirms $0.75/share takeover offer from Ameri Holdings\" data-tweet=\"$CBR - Ciber confirms $0.75/share takeover offer from Ameri Holdings https://seekingalpha.com/news/3250908-ciber-confirms-0_75-share-takeover-offer-from-ameri-holdings?source=tweet\" data-url=\"https://seekingalpha.com/news/3250908-ciber-confirms-0_75-share-takeover-offer-from-ameri-holdings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250907\" data-ts=\"1489495152\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AUPH\" target=\"_blank\">AUPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250907-aurinia-prices-equity-offering-shares-off-26-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aurinia prices equity offering; shares off 26% premarket</a></h4><ul><li>Aurinia Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AUPH' title='Aurinia Pharmaceuticals Inc.'>AUPH</a>) slumps&nbsp;<font color='red'>26%</font>&nbsp;premarket in response to the <a href=\"https://seekingalpha.com/pr/16770304-aurinia-prices-us-150_5-million-public-offering-common-shares\" target=\"_blank\">pricing </a>of its public offering of 22.3M shares of common stock at $6.75. Closing date is March 20.</li><li>Yesterday's close was $10.54.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250907\" data-linked=\"Aurinia prices equity offering; shares off 26% premarket\" data-tweet=\"$AUPH - Aurinia prices equity offering; shares off 26% premarket https://seekingalpha.com/news/3250907-aurinia-prices-equity-offering-shares-off-26-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3250907-aurinia-prices-equity-offering-shares-off-26-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>47&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250906\" data-ts=\"1489494934\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANTH\" target=\"_blank\">ANTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250906-anthera-prices-equity-offering-shares-down-34-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anthera prices equity offering; shares down 34% premarket</a></h4><ul><li>Anthera Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ANTH' title='Anthera Pharmaceuticals, Inc.'>OTC:ANTH</a>) slumps&nbsp;<font color='red'>34%</font>&nbsp;premarket on robust volume in response to its <a href=\"https://seekingalpha.com/pr/16770281-anthera-pharmaceuticals-announces-pricing-15_0-million-public-offering-common-stock-warrants\" target=\"_blank\">pricing </a>of 60M shares of common stock at $0.50 a share and two tranches of warrants.</li><li>Tranche 1 warrants are exercisable at $0.55 and Tranche 2 at $0.50, both on any day after the company files its 8-K. Both are valid for five years.</li><li>Net proceeds will fund R&amp;D expenses for SOLLPURA, manufacturing and general corporate purposes. Closing date is March 17.</li><li>Yesterday's close was $0.6866.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250906\" data-linked=\"Anthera prices equity offering; shares down 34% premarket\" data-tweet=\"$ANTH - Anthera prices equity offering; shares down 34% premarket https://seekingalpha.com/news/3250906-anthera-prices-equity-offering-shares-down-34-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3250906-anthera-prices-equity-offering-shares-down-34-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250905\" data-ts=\"1489494741\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250905-oil-tumbles-to-new-lows-saudis-report-boosted-output\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oil tumbles to new lows as Saudis report boosted output</a></h4><ul><li>While still below the ceiling of 10.058M barrels per day of production, the Saudis <a href=\"https://www.bloomberg.com/politics/articles/2017-03-13/oil-holds-below-49-as-u-s-stockpile-rise-dampens-opec-cuts\" target=\"_blank\">in February boosted output </a>by 263K to 10.011M, according to an OPEC report.</li><li>The number is at odds with other OPEC data showing the Saudis actually cut production further in February.</li><li>Nevertheless, the bears remain in control for now. Up modestly on the session ahead of the news, WTI crude is now&nbsp;<font color='red'>down 1.6%</font>&nbsp;at $47.62 per barrel.</li><li><a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>&nbsp;<font color='red'>-1.1%</font>&nbsp;premarket</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='PowerShares DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/UGA' title='The United States Gasoline ETF, LP'>UGA</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/UHN' title='The United States Diesel-Heating Oil ETF, LP'>UHN</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/OILK' title='ProShares K-1 Free Crude Oil Strategy ETF'>OILK</a>, <a href='https://seekingalpha.com/symbol/OILX' title='Etracs S&P GSCI Crude Oil Total Return Index ETN'>OILX</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3250905\" data-linked=\"Oil tumbles to new lows as Saudis report boosted output\" data-tweet=\"$USO $OIL $UCO - Oil tumbles to new lows as Saudis report boosted output https://seekingalpha.com/news/3250905-oil-tumbles-to-new-lows-saudis-report-boosted-output?source=tweet\" data-url=\"https://seekingalpha.com/news/3250905-oil-tumbles-to-new-lows-saudis-report-boosted-output\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>88&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250903\" data-ts=\"1489494673\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TDW\" target=\"_blank\">TDW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250903-tidewater-wins-new-waiver-extensions-from-lenders-noteholders\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tidewater wins new waiver extensions from lenders, noteholders</a></h4><ul><li>Tidewater (NYSE:<a href='https://seekingalpha.com/symbol/TDW' title='Tidewater, Inc.'>TDW</a>) <font color='green'>+27.4%</font> premarket after saying it <a href=\"https://seekingalpha.com/pr/16769797-tidewater-receives-limited-waiver-extensions-lenders-noteholders\" target=\"_blank\">received extensions</a> of previous waivers from its principal lenders and noteholders to March 27.</li><li>TDW sank to a new 52-week low yesterday but are indicated to open above $1 today; shares have plunged 75% YTD.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250903\" data-linked=\"Tidewater wins new waiver extensions from lenders, noteholders\" data-tweet=\"$TDW - Tidewater wins new waiver extensions from lenders, noteholders https://seekingalpha.com/news/3250903-tidewater-wins-new-waiver-extensions-from-lenders-noteholders?source=tweet\" data-url=\"https://seekingalpha.com/news/3250903-tidewater-wins-new-waiver-extensions-from-lenders-noteholders\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250901\" data-ts=\"1489494342\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLX\" target=\"_blank\">PLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250901-protalix-continues-up-move-shares-ahead-4-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Protalix continues up move, shares ahead 4% premarket</a></h4><ul><li>Micro cap Protalix BioTherapeutics (NYSEMKT:<a href='https://seekingalpha.com/symbol/PLX' title='Protalix BioTherapeutics, Inc'>PLX</a>) perks up&nbsp;<font color='green'>4%</font>&nbsp;premarket on average volume. Shares have rallied almost 40% since Friday.</li><li>The company will <a href=\"https://seekingalpha.com/pr/16766444-protalix-biotherapeutics-hold-full-year-2016-financial-results-corporate-update-conference\" target=\"_blank\">release </a>its Q4 and 2016 results on Thursday morning. Shares have been on a tear since January when the company announced positive preliminary data from a mid-stage study of AIR DNase (alidornase alfa) in patients with cystic fibrosis.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3233063-protalix-bios-cf-candidate-shows-encouraging-results-mid-stage-study-shares-5-percent\" target=\"_blank\">Protalix Bio's CF candidate shows encouraging results in mid-stage study; shares up 5% premarket</a> (Jan. 3)</li></ul><div class=\"tiny-share-widget\" data-id=\"3250901\" data-linked=\"Protalix continues up move, shares ahead 4% premarket\" data-tweet=\"$PLX - Protalix continues up move, shares ahead 4% premarket https://seekingalpha.com/news/3250901-protalix-continues-up-move-shares-ahead-4-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3250901-protalix-continues-up-move-shares-ahead-4-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250900\" data-ts=\"1489494224\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KNDI\" target=\"_blank\">KNDI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250900-kandi-technologiesminus-10-after-warning-on-restatements\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kandi Technologies -10% after warning on restatements</a></h4><ul> <li>Kandi Technologies Group (NASDAQ:<a href='https://seekingalpha.com/symbol/KNDI' title='Kandi Technologies Group, Inc.'>KNDI</a>) discloses that it need to make adjustments to its results for 2014, 2015 and three quarters of 2016. The changes are not expected to alter the reported net income for the periods.</li> <li>The company says that it will reassess internal controls and compliance protocols due to the reporting issues.</li> <li><a href=\"https://seekingalpha.com/filing/3458067\" target=\"_blank\">SEC Form 8-K</a></li>  <li>KNDI <font color='red'>-10.34%</font> premarket to $3.90.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3250900\" data-linked=\"Kandi Technologies -10% after warning on restatements\" data-tweet=\"$KNDI - Kandi Technologies -10% after warning on restatements https://seekingalpha.com/news/3250900-kandi-technologiesminus-10-after-warning-on-restatements?source=tweet\" data-url=\"https://seekingalpha.com/news/3250900-kandi-technologiesminus-10-after-warning-on-restatements\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250899\" data-ts=\"1489494145\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLW\" target=\"_blank\">GLW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250899-corning-downgraded-to-neutral-goldman-sachsminus-1_5-pre-market\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Corning downgraded to Neutral at Goldman Sachs; -1.5% pre-market</a></h4><ul><li>Though expecting Corning's next stage of growth to generate via diversification (double-sided glass devices next major driver), <a href=\"http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Downgrades+Corning+%28GLW%29+to+Neutral%2C+Sees+Upside+As+Limited+Following+Outperformance+Since+April+2016+Addition+To+Conviction+Buy+List/12663912.html\" target=\"_blank\">analyst Doug Clark</a> considers associated opportunities already factored into present&nbsp;16x NTM P/E (compared to 13x 5-year average)&nbsp;multiple subsequent the company's&nbsp;<a href=\"https://seekingalpha.com/news/3236980-corning-plus-3_2-percent-premarket-q4-estimates\" target=\"_blank\">strong Q4 2016 reporting</a>&nbsp;(shares&nbsp;<font color='green'>+11%</font>&nbsp;since).</li><li>Rating from Conviction Buy, price target $29. Corning (NYSE:<a href='https://seekingalpha.com/symbol/GLW' title='Corning Inc.'>GLW</a>) $27.30.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250899\" data-linked=\"Corning downgraded to Neutral at Goldman Sachs; -1.5% pre-market\" data-tweet=\"$GLW - Corning downgraded to Neutral at Goldman Sachs; -1.5% pre-market https://seekingalpha.com/news/3250899-corning-downgraded-to-neutral-goldman-sachsminus-1_5-pre-market?source=tweet\" data-url=\"https://seekingalpha.com/news/3250899-corning-downgraded-to-neutral-goldman-sachsminus-1_5-pre-market\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250897\" data-ts=\"1489493840\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RSLS\" target=\"_blank\">RSLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250897-enteromedics-vbloc-featured-on-tv-show-shares-ahead-21-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EnteroMedics&#39; vBloc featured on TV show; shares ahead 21% premarket</a></h4><ul><li>EnteroMedics (ETRM) is up&nbsp;<font color='green'>21%</font>&nbsp;premarket on average volume in apparent response to the <a href=\"https://seekingalpha.com/pr/16769746-enteromedics-vbloc-neurometabolic-therapy-featured-doctors-tv-show\" target=\"_blank\">news</a> that its vBloc Therapy will be featured on a daytime talk show called \"The Doctors\" today. Frank Chae, M.D., FACS, Chief Surgeon and Head of the Bariatric Center at Sky Ridge Medical Center in Colorado and one his patients who received vBloc to treat her obesity will discuss the benefits of the system and her battle to control her weight.</li><li>The company's Maestro vBloc is&nbsp;a pacemaker-like device that delivers vagal nerve blocking therapy via electrodes that are surgically implanted subcutaneously in the abdomen. The electrodes are placed in contact with the trunks of the vagus nerves just above the junction between the esophagus and the stomach. The device intermittently blocks vagal nerve signals throughout the patient's waking hours which produces the sensation of fullness.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250897\" data-linked=\"EnteroMedics&#39; vBloc featured on TV show; shares ahead 21% premarket\" data-tweet=\"$RSLS - EnteroMedics&#39; vBloc featured on TV show; shares ahead 21% premarket https://seekingalpha.com/news/3250897-enteromedics-vbloc-featured-on-tv-show-shares-ahead-21-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3250897-enteromedics-vbloc-featured-on-tv-show-shares-ahead-21-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250881\" data-ts=\"1489492182\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARRS\" target=\"_blank\">ARRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250881-arris-internationalplus-4-goldman-buys-dip\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arris International +4% as Goldman buys the dip</a></h4><ul><li>The company's product mix shift to network and cloud from set-top boxes should drive multiple expansion for the shares, says analyst Doug Clark, upgrading to Buy from Neutral.</li><li>The $32 price target suggests almost 30% upside.</li><li><a href='https://seekingalpha.com/symbol/ARRS' title='ARRIS International plc'>ARRS</a>&nbsp;<font color='green'>+4.1%&nbsp;</font>to $26 premarket.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3250881\" data-linked=\"Arris International +4% as Goldman buys the dip\" data-tweet=\"$ARRS - Arris International +4% as Goldman buys the dip https://seekingalpha.com/news/3250881-arris-internationalplus-4-goldman-buys-dip?source=tweet\" data-url=\"https://seekingalpha.com/news/3250881-arris-internationalplus-4-goldman-buys-dip\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250876\" data-ts=\"1489491539\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHC\" target=\"_blank\">BHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250876-ackmans-loss-on-valeant-be-over-5b-shares-slip-another-12-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ackman&#39;s loss on Valeant could be over $5B; shares slip another 12% premarket</a></h4><ul><li>Investors in Valeant Pharmaceuticals (VRX)&nbsp;continue to follow hedge fund honcho Bill Ackman to the exits. Shares are down&nbsp;<font color='red'>12%</font>&nbsp;premarket on robust volume.</li><li>Ackman's Pershing Square Capital Management, L.P. could have lost over $5B from its ill-fated investment in the beaten-down drug firm. Pershing last owned 27,234,432 shares, which were sold at $11 for proceeds just shy of $300M. In March 2015, it owned 34,118,551 shares and derivatives when the stock was at $200 (&gt;$6.8B) so the shares just liquidated were valued at ~$5.45B, implying a loss of ~$5.15B.</li><li>At its current value, Pershing stated that its Valeant position represented 1.5 - 3.0% of its funds, but required an inordinate amount of time and resources so it elected to sell and realize the tax loss.</li><li>Mr. Ackman and Pershing Vice Chairman Steve Fraidin will remain on Valeant's board until the Annual Meeting but will not stand for re-election.</li><li>Source: StreetInsider</li></ul><div class=\"tiny-share-widget\" data-id=\"3250876\" data-linked=\"Ackman&#39;s loss on Valeant could be over $5B; shares slip another 12% premarket\" data-tweet=\"$BHC - Ackman&#39;s loss on Valeant could be over $5B; shares slip another 12% premarket https://seekingalpha.com/news/3250876-ackmans-loss-on-valeant-be-over-5b-shares-slip-another-12-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3250876-ackmans-loss-on-valeant-be-over-5b-shares-slip-another-12-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>60&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250873\" data-ts=\"1489491225\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GDOT\" target=\"_blank\">GDOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250873-suntrust-sees-runway-for-green-dot\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SunTrust sees more runway for Green Dot</a></h4><ul> <li>SunTrust lifts Green Dot (NYSE:<a href='https://seekingalpha.com/symbol/GDOT' title='Green Dot Corporation'>GDOT</a>) to a Buy rating after having the payments stock set at Hold.</li> <li>The investment firm <a href=\"https://twitter.com/Briefingcom/status/841599403966132224\" target=\"_blank\">hikes</a> up its price target to $40 from $28 to rep 33% upside potential from yesterday's closing price of $30.16.</li> <li>Shares of Green Dot are already up 28% YTD, topping out this year yesterday at $30.41.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3250873\" data-linked=\"SunTrust sees more runway for Green Dot\" data-tweet=\"$GDOT - SunTrust sees more runway for Green Dot https://seekingalpha.com/news/3250873-suntrust-sees-runway-for-green-dot?source=tweet\" data-url=\"https://seekingalpha.com/news/3250873-suntrust-sees-runway-for-green-dot\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250862\" data-ts=\"1489490006\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EEFT\" target=\"_blank\">EEFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250862-euronet-worldwide-makes-run-for-moneygram\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Euronet Worldwide makes a run for Moneygram</a></h4><ul> <li>Euronet Worldwide (NASDAQ:<a href='https://seekingalpha.com/symbol/EEFT' title='Euronet Worldwide, Inc.'>EEFT</a>) proposes to buy MoneyGram International (NYSE:<a href='https://seekingalpha.com/symbol/MGI' title='MoneyGram International, Inc.'>MGI</a>) for $15.20 per share to value the&nbsp;company at more than $1B, in addition to the assumption of approximately $940M in debt.</li>    <li>The proposal represents a premium of ~15% over the Ant Financial Services Group offer from earlier this year.</li><li>The company forecasts cost synergies from a combination of over $60M in the second year after closing.</li><li>Source: <a href=\"https://seekingalpha.com/pr/16770149-euronet-worldwide-proposes-acquire-moneygram-15_20-per-share\" target=\"_blank\">Press Release</a></li><li>MGI&nbsp;<font color='green'>+21.25%</font>&nbsp;premarket to $15.35.</li></ul><div class=\"tiny-share-widget\" data-id=\"3250862\" data-linked=\"Euronet Worldwide makes a run for Moneygram\" data-tweet=\"$EEFT $EEFT $MGI - Euronet Worldwide makes a run for Moneygram https://seekingalpha.com/news/3250862-euronet-worldwide-makes-run-for-moneygram?source=tweet\" data-url=\"https://seekingalpha.com/news/3250862-euronet-worldwide-makes-run-for-moneygram\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3250837\" data-ts=\"1489486159\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YY\" target=\"_blank\">YY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3250837-yy-beats-0_43-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">YY beats by $0.43, beats on revenue</a></h4><ul><li>YY (NASDAQ:<a href='https://seekingalpha.com/symbol/YY' title='YY Inc.'>YY</a>): Q4 EPS of $1.46 <font color='green'>beats by $0.43</font>.</li><li>Revenue of $357.8M (+30.8% Y/Y)&nbsp;<font color='green'>beats by $5.77M</font>.</li><li>Shares <font color='green'>+2.1%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/16770057-yy-reports-fourth-quarter-full-year-2016-unaudited-financial-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3250837\" data-linked=\"YY beats by $0.43, beats on revenue\" data-tweet=\"$YY - YY beats by $0.43, beats on revenue https://seekingalpha.com/news/3250837-yy-beats-0_43-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3250837-yy-beats-0_43-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>46&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":70,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}